Oxygen Binding Thermodynamics of Human Hemoglobin in the Red Blood Cell by Hill, Kyle K
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Student Research Projects, Dissertations, and 
Theses - Chemistry Department Chemistry, Department of 
Spring 3-2021 
Oxygen Binding Thermodynamics of Human Hemoglobin in the 
Red Blood Cell 
Kyle K. Hill 
University of Nebraska-Lincoln, kyhill3@gmail.com 
Follow this and additional works at: https://digitalcommons.unl.edu/chemistrydiss 
 Part of the Analytical Chemistry Commons, and the Physical Chemistry Commons 
Hill, Kyle K., "Oxygen Binding Thermodynamics of Human Hemoglobin in the Red Blood Cell" (2021). 
Student Research Projects, Dissertations, and Theses - Chemistry Department. 106. 
https://digitalcommons.unl.edu/chemistrydiss/106 
This Article is brought to you for free and open access by the Chemistry, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Student Research 
Projects, Dissertations, and Theses - Chemistry Department by an authorized administrator of 
DigitalCommons@University of Nebraska - Lincoln. 
OXYGEN BINDING THERMODYNAMICS OF HUMAN HEMOGLOBIN 











Presented to the Faculty of 
The Graduate College at the University of Nebraska 
In Partial Fulfillment of Requirements 


















OXYGEN BINDING THERMODYNAMICS OF HUMAN HEMOGLOBIN  
IN THE RED BLOOD CELL  
Kyle Kelly Hill, Ph.D. 
University of Nebraska, 2021 




We report for the first time the binding constants and Hill numbers for oxygen in the red 
blood cell under physiological conditions.  When compared to our results for hemoglobin 
in solution, our results show conclusively that hemoglobin binds oxygen more tightly and 
with lower co-operativity when packed in the red blood cell.  At 18°C, these differences 
are striking: the respective half-saturation values are 15.57 µM (in red blood cells) and 
18.83 µM (in solution), with corresponding Hill numbers of 2.475 (in red blood cells) and 
2.949 (in solution).  The optical complications that arise from high turbidity of red blood 
cell suspensions have been overcome via instrumental and analytical innovations.  First, a 
modified internal cavity absorption meter (ICAM) using a suspension of strongly 
scattering milk particles yielded long optical path lengths, amplifying the target signal.  
Second, the detection of oxygen binding from 600 to 670 nm eliminated the multiple 
unwanted wavelength dependences of apparent fractional saturation found in the 
conventional 535 to 580 nm range.  Finally, a transfer function made it possible to extract 
all thermodynamics data from the scattered light.  Since the hemoglobin tetramer expands 
when it releases oxygen, our work suggests that dense packing of hemoglobin in the RBC 
must constrain this molecular expansion.  The higher oxygen affinity and lower co-
operativity results in a substantially more distributed delivery of oxygen into diverse 
body tissues, such as the lungs and the brain.  Furthermore, consequent thermodynamic 
studies suggest that the differences arise mostly from an entropy difference between 
hemoglobin in the red blood cell and hemoglobin free in solution.  All of these results 
contrast sharply with the decades-long assumption that the behavior of hemoglobin free 
in solution is an appropriate model for understanding the physiology of oxygen binding 
and delivery, and that those curves are physiologically relevant.
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1. Introduction to Hemoglobin 
Physiology of Human Hemoglobin  
 In the human body, hemoglobin serves several major functions, the most 
important function is delivery of oxygen from the lungs to the tissues.  The smallest 
branches of the lungs are called alveoli, an environment with high oxygen concentration.  
Gas exchange occurs in the alveoli, where carbon dioxide passes from the blood to the 
lungs. Oxygen binds to the hemoglobin in the red blood cell.  After passing through the 
heart, the red blood cells travel through the vascular system deliver oxygen to the tissues.  
The oxygen unloaded from hemoglobin travels by diffusion to myoglobin, which has a 
higher affinity toward oxygen than hemoglobin.  Finally, the oxygen travels to 
cytochrome oxidase in the electron transfer system, which has a higher oxygen affinity 
than myoglobin.  Hemoglobin α and β subunits have very similar structures, and both are 
similar to myoglobin.  However, hemoglobin is a remarkably efficient oxygen carrier and 
is able to use up to ninety percent of its potential oxygen-carrying capacity efficiently.  
Under similar physiological conditions, myoglobin would be able to use only seven 
percent of its potential oxygen-carrying capacity.  Myoglobin exists as a monomer and 
functional hemoglobin is a tetramer.  The tetramer structure allows hemoglobin to bind 
oxygen cooperatively, meaning that the binding of oxygen to a single heme increases the 
likelihood that the remaining chains will bind oxygen.  This is due to the allostery of 
hemoglobin.  The conformation of hemoglobin changes from the oxygenated state to the 
deoxygenated state, depending upon the ligands bound to the hemoglobin.  The presence 




1.1 Hemoglobin Conformational Changes 
Hemoglobin is vital to life, as it transports oxygen from the lungs to the tissues 
and helps with the transport of carbon dioxide from the tissues to the lungs.  The binding 
affinity increases during the stepwise binding of four oxygen molecules leading to a 
sigmoidal binding curve.  Since the beginning of the century hemoglobin has attracted 
numerous investigations because of its interesting physiologically and physical 
interactions with ligands.  Although the structure and function of hemoglobin has been 
investigated more extensively than all other allosteric proteins, the molecular mechanism 
of its action is still unclear.   
For over one hundred years, it has been known that hemoglobin crystalizes in two 
distinct states depending on the degree of oxygenation.  In 1893, deoxygenated 
hemoglobin crystals were observed to shatter when exposed to oxygen, suggesting that 
hemoglobin changed in size during oxygenation.1,2  Further evidence of the two states 
came from x-ray crystallography in 1959 and in 1963, when Perutz elucidated the 
structure of oxygenated hemoglobin and deoxygenated hemoglobin, respectively.3,4  Each 
of the two α- and two β-globins contain a heme ring: a porphyrin with one central Fe 
atom that can bind and release one oxygen molecule.  In oxygenated hemoglobin 
conformation, the heme lies in an isolated pocket where it is tightly wedged between the 
16 side chains of the globin.  This constrains the iron to lie within the plane of the 
porphyrin ring.  The iron is hexacoordinate with four bonds to the porphyrin ring, one 
bond to histidine, and the sixth to the oxygen.  In the deoxygenated conformation, the 
iron is in a 5-coordinated form, losing the interaction with oxygen. The iron becomes 
displaced from the porphyrin plane by 0.4 Å.5   The distal valine obstructs the 
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deoxygenated conformation on the ligation side and this obstruction cannot be cleared 
without a change in the polypeptide structure.  Within these two different conformations, 
the globins determine the relationship of the iron within the porphyrin ring.  As pointed 
out by Perutz and others, the dominant structural change between all four globins can be 
described as the α1β1 and α2β2 dimers remaining rigid while the contacts between α1β2, 
α2β1, α1α2, and β1β2 move relative to each other.6  During deoxygenation, the α1α2, α1β1, 
and α2β2 heme distances remain stationary while the α1β1 and α2β2 act as hinges.  Most 
notably, the β1β2 heme distance increases 5Å (fig. 1.1).  This led Perutz to describe 
hemoglobin functioning as a "molecular lung in reverse," contracting as it binds oxygen 
and expanding as it releases oxygen.7 
Tertiary Structural Changes Upon Oxygenation 
 The changes in the tertiary structure of hemoglobin are small in scale compared to 
those of the quaternary structure, but the changes in the tertiary structure induce the 
quaternary structural changes.  The displacement of the iron atom gives rise to movement 
of the proximal histidine.  This causes the associated alpha helix to move toward the 
heme plane.  This movement is propagated to other helices, and further amplified toward 
the carboxyl termini of the hemoglobin monomer.  In deoxyhemoglobin, two tyrosine 
side chains occupy pockets between two helices.  The tyrosine hydroxyl groups are 
hydrogen-bonded to the carbonyl groups of two valines.  Upon oxygenation, the tyrosine 
side chains are expelled from the pockets, giving rise to the rupture of salt bridges 
involving carboxyl terminal residues.  Upon expulsion of the tyrosine side chains, the 
thiol group of a cysteine moves into the tyrosine pocket, which is competed for by these 
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two side chains.  The rupture of the salt bridges in the carboxyl terminal region causes the 
further rupture or weakening of other salt bridges.   
Quaternary Structural Changes Upon Oxygenation 
 The binding of oxygen to one hemoglobin subunit is accompanied by a complete 
rearrangement of the four monomers.  From the perspective of an α1 monomer, α2 is turns 
16° and shifts by 2.1 Å, β1 by 3.7° and 1.9 Å, and β2 by 13.5° and 1.9 Å.  Upon this 
transition, the symmetry is preserved but a new axis replaces the previous.  There is no 
significant conformational change at the α1-β1 contact, but the α1-β2 contact region 
undergoes significant changes.  The monomers shift by 6 Å, resulting in a change in the 
number, type and combination of the amino acid chain interactions.  The amino acid 
residues involved in the bonds or contacts with the heme group, in the α1-β2 contact 
region, are all important for the physiological functioning of hemoglobin, and almost all 
of them are ubiquitous.   
1.2 Hemoglobin Disease States 
Numerous disease states of hemoglobin exist.  They are caused by abnormal 
levels of hemoglobin monomers or the expression of abnormal hemoglobins.  The 
majority of hemoglobin in human adults is hemoglobin A, a tetramer consisting of two α- 
and two β-globins.  Although its physiological role is unclear, 1-3% of all human 
hemoglobin tetramers exist as two α-globins and two δ-globins, hemoglobin A2.  During 
fetal development, humans produce hemoglobin F consisting of two α- and two γ-
globins.  Hemoglobin F has a higher oxygen affinity than hemoglobin A.  After birth, 
most of the γ-globins are replaced by β-globins with the result that 1-4% of hemoglobin 
in the average adult human is hemoglobin F.  
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Many hemoglobin variants can be expressed (Table 1.1).  The most common 
abnormal hemoglobin expressed is the s-globin, the cause of sickle cell anemia.8  The s-
globin gene is autosomal recessive, replacing the β-globin gene.  When both inherited 
genes express the s-globin, sickle cell anemia occurs.  When one inherited gene expresses 
s-globin and the other expresses β-globin, the individual’s oxygen transport system is not 
much effected but they experience fewer effects during malarial infections.  This led to 
evolutionary selection for the gene in malaria-stricken portions of the world.9  Carriers 
will only show symptoms under very low oxygen concentration, or when dehydrated.   
Sickle cell disease can be devasting for humans with the double recessive gene. 
While the symptoms can vary from person to person, the major effects are anemia, 
bacterial infections, swelling of the hands and feet, and stroke.  Humans with the disease 
can experience a sickle cell crisis, including vaso-occlusion and hemolysis of the red 
blood cells lasting roughly a week.10  This crisis can be brought about by infection, 
dehydration, or acidosis, but no predisposing cause has yet to be identified.11  The life 
expectancy of sickle cell disease patients is 30-60 years in countries with modern 
medicine.12 
The sickle cell disease state was the first genetic disease identified.13  The s-
globin gene is a single nucleotide mutation in the β-globin gene, exchanging a guanine-
adenosine-guanine codon for a guanine-thymine-guanine codon.  The β-globin glutamine 
at position 6 is replaced with valine.  The hemoglobin S structure does not differ  
substantially from hemoglobin A, and in dilute solution both have physiologically similar 
oxygen-binding thermodynamics.14,15  However, at high hemoglobin concentration in the 
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red blood cell, low oxygen concentration brings about sickling of the red blood cell when 
the hemoglobin polymerizes due to an exposed hydrophobic portion of the tetramer.16  
The sickling occurs most drastically in deoxygenated blood and is most problematic in 
the capillaries.  Thus, the disease state requires the concentrated hemoglobin environment 
that occurs within the red blood cell. The majority of robust hemoglobin oxygen-binding 
equilibrium studies were done in dilute solution.  In contrast, studies of the 
thermodynamics of hemoglobin oxygen-binding within the red blood cell are limited.  
We sought to develop novel robust experimentation to compare hemoglobin oxygen-








HbS/HbC8 HbB mutation: E6K 
 
Sickling of deoxygenated RBCs, anemia, 
poor circulation, early death  
HbE17,18 HbB mutation: E26K 
 
Growth retardation, splenomegaly, 
hepatomegaly, jaundice, bone abnormalities, 
and cardiovascular problems, early death 
Hb Bart’s19 Hbγ is overexpressed 
and replaces HbA 
Tetramers of 4 fetal hemoglobins are 
insoluble and accumulate in the RBC 







Homozygous: mild anemia and slight 
splenomegaly 
Hb O Arab21 HbB single-point 
mutation: E121K 
 
Heterozygous: mild sickling of deoxygenated 
red blood cells, rare anemia 
Homozygous: major sickling of deoxygenated 




HbB single point 
mutation: E11K 
Heterozygous: asymptomatic 







Hb H23 Impaired production 
of 3 of 4 α-globins 
Hemolytic anemia, splenomegaly, 
hepatomegaly, jaundice, bone deformities 
Hb Lepore24 Fusion of HbB and 
HbD gene loci.  
Hemoglobin consists 
of 2 α-globins and 
2β/δ-globins 
Heterozygous: Asymptomatic 
Homozygous: Severe anemia, splenomegaly, 
hepatomegaly, bone deformities 
Hb M HbB single-point 
mutation: K67E  
Heterozygous: 15-30% levels of 
methemoglobin in the RBC 
Hb Kansas25 HbB single-point 
mutation: N102T 
Heterozygous: raised levels of 
methemoglobin in the RBC 
aMany thalassemias of hemoglobin exist.  The majority of them are pathologically recessive and 
are single-point mutations in the HbB gene, changing a hydrophilic amino acid to a hydrophobic 
residue on the tetramer's outer surface.  These cause misshapen red blood cells upon 
deoxygenation, leading to enlargement of the spleen and liver, bone deformities, and anemia.  
Some single-point mutation exchange a hydrophobic residue for a hydrophilic amino acid in the 
interior of the tetramer, causing high populations of methemoglobin formation.  The major focus 
of thalassemia study is pathological on patient symptoms and genetic causes, with limited studies 




Figure 1.1: Molecular Lung in Reverse: Hemoglobin 
The distance between the oxyhemoglobin β1Fe- β2Fe hemes is 34.6 Å (solid red), which 
expands to 39.6 Å in the deoxyhemoglobin conformation (solid blue).  This relates to a 




1.3 History of Hemoglobin Oxygen-Binding Research 
Hemoglobin has been a model protein for the scientific community for the past 
two hundred years.  Hemoglobin is easy to obtain, and the color makes it easy to work 
with in the lab.  In 1825, Engelhart showed that the iron-to-protein ratio in hemoglobin 
was similar across multiple species.26  In 1878, Bert obtained the first crude hemoglobin 
oxygen-binding measurements using gasometric methods.27  Using similar techniques, 
Bohr found that pH changed the equilibrium of hemoglobin oxygen-binding.28  
Subsequent studies concluded that other molecule concentrations, such as salt and 
diphosphoglycerate, drastically altered the hemoglobin oxygen-binding equilibrium.  
These molecules regulated the hemoglobin oxygen-binding thermodynamics by binding 
to a site other than the active site and were called allosteric effectors.  Further gasometric 
methods developed by Barcroft and Haldane were used to study hemoglobin oxygen-
binding equilibrium.29,30  These gasometric measurements often utilized a Van Slyke 
apparatus.31  The Van Slyke apparatus uses a round-bottom flask filled with a solution of 
deoxygenated hemoglobin.  A measured amount of air with oxygen is introduced to the 
flask and given time to equilibrate.  A small drop in the pressure indicated the binding of 
oxygen to hemoglobin.  These experiments could be used to study hemoglobin oxygen-
binding within the red blood cell.  However, even recent automated gasometric 
measurements take considerable amounts of time and are prone to measurement errors.32  
Later, spectrophometric techniques provided more precise data, allowed for 
multiple measurements per sample, and required much less protein.  As a result, 
spectrophotometric methods have largely replaced the gasometric methods.  Imai, often 
considered Adair’s protégé, worked extensively on the ligand-binding properties of 
10 
 
hemoglobin.  In the 1970s and 1980s, Imai et. al. developed a method to study the 
functional properties of abnormal hemoglobin, and later improved this method to 
determine the oxygen-hemoglobin equilibrium curves.  The Imai method uses the 
absorbance changes of hemoglobin at a single wavelength to determine the oxygen 
saturation and uses an oxygen electrode to determine the oxygen concentration.  A 
solution of oxyhemoglobin was placed into a cell with magnetic stirring, and this cell is 
in the beam of a double-beam spectrophotometer with the path length ranging from 5 to 
25 mm.  The temperature is controlled by water circulating around the cell.  A small 
thermistor is placed within the cell to measure the temperature of the sample.  The gas 
phase above the liquid was filled and continuously replaced with argon or nitrogen, and 
the dissolved oxygen was removed from the solution.  The percent of heme bound with 
oxygen, or fractional saturation, was measured utilizing Beer’s law.  The fractional 
saturations were compared to the solution's oxygen concentration.  These measurements 
allowed for greater resolution, but a considerable problem arose.  Spectrophotometric 
measurements within the red blood cells were limited as the scattered light from the 
turbid solution created too much signal-to-noise.  Most spectrophotometric hemoglobin 
oxygen-binding studies used free hemoglobin. Most spectrophotometric measurements of 
hemoglobin oxygen-binding utilized a hemoglobin concentration of 100 µM to ensure the 
tetramer does not dissociate to dimers.33  This is 200-fold less concentrated than in the 
cell.   
1.4 Chemical Environment of Red Blood Cells 
For most vertebrates, hemoglobin delivers oxygen from the lungs or gills to the 
tissues.  If the protein was used in solution to provide oxygen, then two critical 
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difficulties arise.  First, the iron in the hemoglobin is toxic.34  Second, adequate oxygen 
delivery from the lungs to the tissues would require a viscous solution, putting an 
incredible strain on the heart.35,36  The red blood cell eliminates the iron toxicity by 
containing the iron within a cell membrane and increases oxygen delivery rates by 
maximizing the surface area to volume ratio by adopting a biconcave disc shape.  The red 
blood cells are roughly 90 fL and can expand freely to 150 fL.37,38   
The capillaries are half the diameter of the red blood cell, so the cells bend and 
contort to fit through the capillaries one cell length apart.39–42  The cigar shape increases 
the surface area interaction of the red blood cell with the capillary, thus increasing the 
rate of gas exchange to the surrounding tissues.  The elasticity of the red blood cell 
membrane is maintained by membrane proteins, such as band 3 protein and others.  In the 
arteries and isotonic solutions, the red blood cell has a diameter of 6-8 µm and a 
thickness of 2 µm.  
The red blood cell has a hemoglobin tetramer concentration of 5 mM, which gives 
an average tetramer center-to-center distance of 76 Å, as contrasted to 280 Å for most 
spectrophotometric measurements (fig. 1.2).  In fact, the interior of the red blood cell has 
30-40% less water due to the high concentration of hemoglobin and other proteins.  It 
was our hypothesis that this crowded environment plays a major role in hemoglobin 
oxygen-binding because there are more protein-protein interactions.  To test this 
hypothesis, we used an integrated cavity absorption meter spectrophotometer with novel 
correcting functions to determine the oxygen-binding thermodynamics of hemoglobin in 
12 
 







Figure 1.2: Center-to-Center Distances for Hemoglobin in Solution Compared to in Red Blood Cells 
The typical spectrophotometric experimentation of hemoglobin deoxygenation utilizes hemoglobin concentrations of 100-150 
µM, which is a center-to-center tetramer distance of 280 Å (A, B).32,43,44 The hemoglobin concentration in the RBC ranges from 4810-
5580 µM as a tetramer in the RBC (C,D).45  In the RBC, the tetramer center-to-center distance is 76 Å from literature (sphere 
estimation).  For standard spectrophotometric experimentation, the high concentration of the hemoglobin in the RBC combined with 
the light scattering effect of the RBC in solution prevents spectral measurements.  Due to proximity with other tetramers, we predicted 





2. Integrated Cavity Absorption Meter: Design & Validation 
2.1 Introduction 
Purpose of ICAM Spectrophotometry 
In most previous spectrophotometric studies of hemoglobin oxygen-binding 
equilibria, the measurements were taking using translucent solutions of dilute protein.  At 
visible wavelengths, the wavelength of light is much larger than the diameter of 
hemoglobin at 5 nm, and the sample does not scatter light.  The average solution of 
hemoglobin used in spectrophotometric measurements at 100 µM (tetrameric 
concentration) is translucent.  This concentration is high enough to overwhelm the 
tetramer/dimer dissociation (Kd = 1 µM, under standard conditions), but low enough to 
not overwhelm the signal-to-noise of the spectrophotometer.46  In contrast, a solution of 
red blood cells is turbid.  Human red blood cells are larger than the amplitude of light, 
leading to light scattering and a significant signal-to-noise loss.47  The scattering effects 
have always been a systematic problem in absorption measurements, and there have been 
multiple attempts to correct for this scattering.48  One of these attempts is the Integrating 
Cavity Absorption Meter or ICAM. 
Basic Physical Description of ICAM Setups 
The ICAM spectrophotometer utilizes a round-bottom flask with an entrance and exit 
window, with either the inner or outer diameter of the sphere coated with a highly diffuse 
reflecting white material (fig. 2.1).  The walls reflect scattered light until the sample 
absorbs the photons or the light leaves through either of the windows.49  The 




photomultiplier contrasts the light energy from the sample to a blank.  For instance, 
ICAMs are used in studies of pollution detection or sea particles with low extinction 
coefficients and low concentrations.50,51  The biggest drawback of ICAM 
spectrophotometers is that absorbances do not relate linearly with concentration and do 
not reflect Beer's law.  Nevertheless, over 70 years of theoretical and experimental 
research has resulted in methods to correlate ICAM absorbance measurements with the 
absorbance readings gathered from a spectrophotometer utilizing collimated light.   
History of Relating ICAM Absorbances to Collimated Absorbances 
Initial work on an ICAM began in 1953 when Walsh proposed that, if the light is 
introduced through a small entrance window and the sphere's surface was Lambertian 
reflective, then any point of reflectance in the ICAM will illuminate all other surfaces of 
the wall equally.52  In 1970, Elterman continued the work by devising an integrating 
cavity and deriving the absorbance coefficients based upon the measured absorbances.53  
The calculations assumed that the energy of light at all points of the walls being equal.  In 
1992, Fry continued his work and corrected Elterman's derivations.54,55  The derivations 
use an average pathlength in the ICAM, derived from using the photon energy of the light 
being equal at any one point of the ICAM.  Parkhurst developed the correct equations for 
both spherical and cubic ICAM to obtain absorbance coefficients from measured 
absorbance of the ICAM by considering the precise distribution of path lengths (see 
appendix 5.7).  Instead of treating the ICAM with average energy, Parkhurst integrated 
over the probabilities of all pathlengths within the ICAM.  Using these results, Parkhurst 




follow an exponential complement.  With the corrections, it became possible for us to use 
ICAM measurements to determine the percent of hemoglobin oxygen-binding sites bound 
in a way that is directly proportional to concentration. 
Overview of ICAM Spectrophotometry Validation 
The determination of hemoglobin oxygen-binding thermodynamics requires 
measuring both the percent of hemoglobin oxygen-binding sites bound and oxygen 
concentration in solution.  In our case, the ICAM absorbance measurements determined 
the percent of hemoglobin oxygen-binding sites bound, while a Clark oxygen electrode 
determined the solution's oxygen concentration.56,57  Our initial ICAM experiments had a 
three-fold purpose.  First, we tested Parkhurst’s derivations by determining a transfer 
function.  The transfer function corrected ICAM scattered light absorbance to an 
equivalent collimated absorbance per centimeter.  Second, we tested the transfer function 
by comparing the corrected ICAM measurements to measurements gathered by a 
collimated spectrophotometer using samples that scatter light with those that do not.  
Third, both the oxygen electrode and the optics were tested by deoxygenating reduced 
myoglobin, a simple system with only one parameter to fit.  These experiments laid the 
foundation for utilizing the ICAM to study both hemoglobin in dilute solution and 





2.2 Materials and Methods 
Obtaining Myoglobin Samples 
Horse heart myoglobin was prepared by lysing horse hearts using a modified 
technique from Dr. Bowen.58  Unless otherwise stated, all work was done at 4°C and all 
solutions were autoclaved.  This was carried out by a previous Parkhurst student resulting 
in a sample with 99% purity.  The horse hearts were removed at the slaughterhouse and 
the blood removed with warm water with 0.85% (w/v) sodium chloride.  The auricles, fat 
and connective tissue was trimmed from the ventricles.  The ventricles were ground and 
mixed with water in a 1:1 ratio of one milliliter of water per gram of sample.   
The mixture was stirred well and left overnight.  In the morning, the extract was 
separated from the sample by centrifugation at 1000xg.  The extract was partially purified 
by adding 3M ammonium sulfate, centrifuging at 1000xg, and then collecting the 
supernatant.  The supernatant was placed in a dialysis tube (8 cm diameter), and then was 
placed in a stirred ice bath of saturated ammonium sulfate adjusted to 7.2 pH with 
ammonium hydroxide for 24 hours.  After 24 hours, myoglobin crystals formed.   
The myoglobin crystals were purified by centrifuging the contents of the dialysis 
tube at 1000xg for 10 minutes.  The supernatant was removed, and the crystals were 
resuspended in saturated ammonium sulfate and centrifuged at 250xg for 5 minutes.  The 
supernatant was removed, and the process repeated three times.  The precipitate was 
suspended in saturated ammonium sulfate for 24 hours.  After 24 hours, the crystals 
reformed, and the solution was removed by aspiration.  This process was repeated three 





Metmyoglobin was prepared by adding 0.010 grams of potassium ferricyanide to 
50 mL of autoclaved 100 mM phosphate buffer at pH 7.4 with 1.2 grams of horse heart 
myoglobin.  The ferricyanide was separated from the metmyoglobin by loading it onto a 
G-25 Sephadex gel filtration column.  The sample concentration was determined with a 
collimated spectrophotometer in a 20:1 dilution using the molar extinction coefficient of 
9.5*103 M-1 * cm-1 at 500 nm.  Using the collimated spectrophotometer, a standard 
metmyoglobin spectrum from 400 nm-750nm was taken. 
Reduced Myoglobin Preparation 
The reduced myoglobin was prepared by dissolving 1.200 grams of horse heart 
myoglobin to 50 mL of autoclaved 100 mM phosphate buffer at 7.4 pH with 1% (w/v) 
sodium chloride.  The myoglobin was reduced by adding 0.010 g of sodium dithionite to 
the deoxygenated myoglobin solution.  The deoxygenation prevents the sodium dithionite 
from reacting with oxygen to form peroxides.  Afterward, the diithionite was separated 
from the myoglobin with a G-25 Sephadex column.  
Obtaining Red Blood Cell Samples 
Blood was drawn from Kyle Hill and then collected into citrate tubes at the UNL 
Health Center.  All remaining work was done at 4°C.  On the same day, the blood was 
centrifuged at 1000xg for 3 minutes, and the supernatant discarded. The pelleted sample 
was washed by adding autoclaved 100 mM phosphate buffer at pH 7.4 and 1% (w/v) 
sodium chloride, and then centrifuging again.  This process was repeated until the 




Hemoglobin Preparation in Dilute Solution 
The free hemoglobin in solution was isolated from red blood cells using a 
hypotonic solution.  Unless otherwise stated, all work was done at 4°C and all solutions 
were autoclaved.  The red blood cells were placed in 100 mM phosphate buffer at pH 7.4 
and 1% (w/v) sodium chloride and then centrifuged at 1000xg for 3 minutes.  
Centrifugation and washing were repeated until the supernatant was clear.  The red blood 
cells were lysed, releasing hemoglobin by adding deionized water equivalent to three 
times the volume of the pellet.  This solution was gently mixed by a motorized rocker 
over the course of 20 minutes.  Afterwards, the solution of lysed red blood cells was 
centrifuged at 5000xg for 15 minutes, and the supernatant collected.  The sample 
concentration was measured using a collimated spectrophotometer with the molar 
extinction coefficient at 15.25 L*mmol-1*cm-1 for 576 nm. The solution was filtered 
through a Millipore 0.6 µm filter and stored at 4°C until used.  
ICAM Design: Deflector 
The ICAM design used a 250 mL round-bottom flask with a sidearm, coated on 
the outside with a thick, even layer of white paint.  A bright pen-light was inserted onto 
the open neck of the round-bottom flask in complete darkness to ensure nearly all light 
was contained.  Two windows in the round-bottom flask were directly across from one 
another.  These two windows initially allowed the incident light to pass through the 
round-bottom flask.  In the center top hole, a rubber stopper was placed.  A stainless-steel 
rod was inserted through the center of the rubber stopper.  A deflector was attached to the 




glass lightly brushed with sandpaper.  The opal glass deflects the incident light beam and 
causes the incident light to reflect onto the walls of the ICAM.  When the rubber stopper 
was placed into the top of the round-bottom flask, no incident light reached the exit 
window before being scattered.  Small Mie-scattering effects were eliminated by adding 
2.000 mL of 1% fat milk (Prairie Farms 1% fat milk, quarter gallon).  The milk was 
opened fresh for each ICAM usage.  The light leaving the exit window is completely 
diffused with both the milk and the deflector.   
ICAM: Thermistor 
A stable ICAM temperature (±0.1°C) was maintained by pumping water from a 
temperature-controlled bath through Tygon tubing surrounding the ICAM. The Tygon 
tubing was wrapped around the ICAM 15 times.  The temperature within the ICAM was 
continually measured with a thermistor inserted through a rubber stopper.  The 
temperature was maintained between 15-40°C.   
ICAM: Oxygen Electrode 
The oxygen concentration in the ICAM was measured using a YSI 5300 “Clark 
electrode” inserted through the sidearm of the round-bottom flask.56  When placed into 
the sidearm, an airtight seal was made with silicone cement.  The calculation of the 
oxygen concentration for air-equilibrated water is in appendix 5.7.  The oxygen 
concentration in the ICAM solution was recorded every twenty seconds.  The oxygen 
concentration data points were LOWESS-fitted to estimate the oxygen concentration at 
every second.  All three parts of the ICAM spectrophotometer - the oxygen electrode, the 






Figure 2.1: Light Path through the ICAM  
The collimated light from the incident photons traveled through the Entrance Window.  
Once inside, the photons were Lambertian scattered by milk globules.  The baffle 
prevented any collimated light from reaching the Exit Window.  Upon leaving the Exit 






Figure 2.2: Instrumentation to Measure Oxygen-Binding Thermodynamics of 
Hemoglobin 
The oxygen concentration in the ICAM solution was monitored with an oxygen 
electrode. Spectral data was obtained using a Cary 300 spectrophotometer.  The 
temperature of the solution was monitored with a thermistor.  The device was wrapped in 
Tygon-tubing and temperature-controlled by flowing water from a water bath set from 4 










The ICAM solution was stirred to keep the milk particles suspended and turbidity 
at a maximum.  Also, the Clark electrode requires a stirred solution for accurate 
measurements.59  Below the ICAM round-bottom flask was a pneumatic stir plate housed 
in a machined aluminum block.  The pneumatic stir plate generated little heat during 
operation, which allowed for easier temperature control of the ICAM.  An air pressure of 
18 psi was obtained with 2.7 revolutions per second.  A Teflon-coated 2-centimeter egg-
shaped magnet was placed into the ICAM round-bottom flask and stirred the solution.  
The absorbance of a solution of hemoglobin was held stable for 7 hours. 
ICAM: Optical Alignment 
The ICAM round-bottom flask, the oxygen electrode and thermistor, the 
pneumatic stir plate housed in an aluminum block, and the camera mount were placed 
inside the Cary 300 (Varian Instruments, Agilent) and covered with a Styrofoam block.  
Thick felt was layered onto the Styrofoam block to ensure no outside light entered the 
sample chamber.  The Cary 300 was a double-beam spectrophotometer that used a series 
of mirrors and baffles to switch between the reference beam and the incident beam every 
33 milliseconds.  The Varian Optical Spectroscopy Instrument program on Windows XP 
controlled the Cary 300 and was used for measurements.  Spectral data were transferred 
to Excel, Graphpad 6, and Origin for analysis. 
To align the optics, white light was passed through the reference and incident 




filled with 200 milliliters of a clear non-scattering solution.  Alignment was achieved 
when the absorbance of the emitted light was at a minimum.  Next, the rubber stopper 
holding the deflector was placed into the top of the ICAM round-bottom flask and the 
deflector was adjusted until the absorbance was at a maximum.  Afterwards, a neutral 
density filter was placed in the reference beam, such that the readings from reference 
beam and the incident beam were in the logarithmic range of ± 1.  The ICAM 
spectrophotometer was blanked for zero absorbance after adding 1% (w/v) of 1% fat milk 
to the ICAM round-bottom flask.  The absorbance at each of the three alignments was 
consistently reproducible.   
Deoxygenation of ICAM Solution Through Low Pressure Nitrogen Airflow 
The ICAM solution was deoxygenated by nitrogen entering through an 18-gauge 
needle inserted into a rubber stopper.  The nitrogen to the first needle was provided by a 
pneumatic tube attached to a nitrogen tank set at 5-15 psi.  The nitrogen flowed through a 
bubbler and then into the ICAM head space (fig. 2.3).  This ensured the nitrogen was 
water-saturated and did not dehydrate the solution.  An out-flow needle attached to 
pneumatic tubing ensured the pressure in the ICAM in the head space remained at lab air 




   
Figure 2.3: Flow of Water-Saturated Nitrogen Gas into the Air Space Led to Gentle 
Deoxygenation of the Solution 
Nitrogen flow displaced oxygen in the solution in the air-tight ICAM. Two needles 
through a rubber stopper allowed water-saturated nitrogen inflow and air outflow over the 
solution.  The hemoglobin deoxygenated with the solution.  As the solution 
deoxygenated, so did the hemoglobin in the solution.  Constant stirring ensured the 




   
Figure 2.4: Instrumentation to Measure Oxygen-Binding Thermodynamics of 
Hemoglobin 
During deoxygenation of the ICAM solution, the oxygen concentration and 
spectral data were collected to construct the oxygen-binding curves of hemoglobin.  A is 
the input nitrogen line and B is the output air line.  C is the baffle, D is the thermistor, E 
is the oxygen electrode fully submerged in the solution, and F is a stir bar. The air 
tightness of the ICAM was ensured with rubber stoppers, shown here as cross-hatched 





Collimated Spectrophotometer: HPDA 8452 
Collimated absorbance measurements were obtained in a Hewlett Packard Diode 
Array 8452 spectrophotometer.  Absorbance measurements were acquired every 2 nm 
after zeroing the instrument.  The half-width full-max of wavelengths for each 
photomuliplier was ± 0.1 nm, and the data was collected in multiples of 100 milliseconds.  
The On-Line Instrument Systems Program was used to collect data from the HPDA.  The 
data was exported to Excel, Graphpad 6, and Origin for further analysis.   
Data Acquisition: Metmyoglobin Collimated Spectra 
The spectrum of 22 µM metmyoglobin in 100 mM phosphate buffer at pH 7.4 
was obtained using a HPDA 8452 spectrophotometer.  A total of ten spectra were 
acquired from 180 to 820 nm.  Then, the ten spectra were Savitsky-Golay smoothed and 
averaged.  
Data Acquisition: Metmyoglobin ICAM Spectra 
The ICAM spectra of metmyoglobin concentrations at various concentrations 
(1100 nM, 1900 nM, 3100 nM, and 4600 nM) were taken in the ICAM 
spectrophotometer.  The metmyoglobin solution was added to the ICAM containing 
200.0 milliliters of 100 mM phosphate buffer at pH 7.4 and 2.000 milliliters of 1% milk.  
A total of ten spectra at each concentration were recorded from 500 to 750 nm.  The 




Data Acquisition: Obtaining the Spectrum of Oxygenated Hemoglobin in the Red Blood 
Cells using Collimated Spectrophotometry 
 The spectra of oxygenated hemoglobin in the red blood cells were obtained using 
a thin-layer two cells thick, and this eliminated nearly all the light-scattering.  The cells 
were centrifuged at 1000xg and the supernatant carefully removed.  This process packed 
the red blood cells and the sample had very high viscosity.  50.0 microliters of packed red 
blood cells were placed on a microscope slide using a modified glass pipette with a large 
diameter at the tip.  A cover slip was gently placed on the packed red blood cells.  Mild 
pressure on the cover slip resulted in the packed red blood cells forming a uniform non-
scattering layer between 20 to 30 µm in thickness.  The thin-layer of red blood cells was 
placed in the incident beam of the HPDA 8452 spectrophotometer and the spectra were 
acquired.  A total of ten spectra were recorded every second.  Each spectrum was 
Savitsky-Golay smoothed and averaged. 
Data Acquisition: Obtaining Spectrum of Oxygenated Hemoglobin in Red Blood Cell 
using ICAM Spectrophotometry  
The spectra of oxyhemoglobin in the red blood cells were acquired by adding 600 
µL of 10% hematocrit red blood cells in 100 mM phosphate buffer at pH 7.4 with 1% 
(w/v) sodium chloride to 200.0 milliliters of the same buffer with 2.000 milliliters of 1% 
milk in the ICAM.  A total of ten spectra was acquired from 500 to 750 nanometers with 
a Cary 300 spectrophotometer.  Each spectrum was Savitsky-Golay smoothed and 




Data Acquisition: Spectra of Oxygenated Hemoglobin at 30 µM using ICAM 
Spectrophotometry 
The ICAM spectra of oxygenated hemoglobin in dilute solution were obtained by 
adding 3.000 mL of 2090 µM hemoglobin in 100 mM phosphate buffer at pH 7.4 to 
200.0 mL of the same buffer with 2.000 mL of 1% milk in the ICAM.  A total of ten 
spectra were acquired from 500 to 750 nanometers with a Cary 300 spectrophotometer.  
Each spectrum was Savitsky-Golay smoothed and then all spectra were averaged together 
for a single spectrum.  
Data Acquisition: Spectra of Oxygenated Hemoglobin at 30 µM using Collimated 
Spectrophotometry  
The collimated spectra of 30 µM oxygenated hemoglobin in 100 mM phosphate 
buffer at pH 7.4 were taken in the HPDA 8452 spectrophotometer.  A total of ten spectra 
were acquired from 180 to 820 nm.  Then, ten spectra were Savitsky-Golay smoothed and 
averaged. 
Data Acquisition: Deoxygenation of Myoglobin 
 The myoglobin was deoxygenated in the ICAM while the absorbance was 
acquired with the Cary 300 spectrophotometer and the oxygen concentration was 
acquired using the oxygen electrode.  First, 200.0 µL of 310 µM myoglobin in 100 mM 
phosphate buffer at pH 7.4 was added to 200.0 mL of the same buffer with 2.000 mL of 
1% milk in the ICAM.  The solution was deoxygenated at 22°C over the course of 75 
minutes (see Deoxygenation of ICAM Solution Through Low Pressure Nitrogen 




absorbances were Savitsky-Golay smoothed.  Oxygen electrode readings were acquired 
from the YSI 5300 control panel every 20 seconds.  The oxygen concentration data points 
were LOWESS-fitted to estimate the oxygen concentration at every second. 
2.3 Results 
Overview of ICAM Spectrophotometry Validations 
The goal of the work described in this chapter was to develop and validate the 
instrumentation.  This involved determining the two parameters of the transfer function, 







Table 2.1: Parameters & Fits of ICAM Spectrophotometry 
Validation Process Parameter/Constant/Fit 
Establishing Transfer Function S 
Establishing Transfer Function D 
Validating Transfer Function The Standard Deviation of the 
Comparison of the Spectrum of 
Oxygenated Hemoglobin in the Red 
Blood Cells determined using ICAM 
Spectrophotometry and Collimated 
Spectrophotometry 
Validating Transfer Function The Standard Deviation of the 
Comparison of Oxygenated 
Hemoglobin in Solution Spectra 
determined using ICAM 
Spectrophotometry and Collimated 
Spectrophotometry 
Verifying the Oxygen Electrode A0 
Verifying the Oxygen Electrode Aꝏ 
Verifying the Oxygen Electrode and Transfer 
Function 









The transfer function transformed ICAM absorbance (AICAM) into collimated 
absorbance (ACOLL).  This was necessary as the AICAM did not relate linearly with 







In this equation, AICAM was the absorbance in the ICAM, S was a scalar parameter, D was 
the exponential decay parameter, and ACOLL was the equivalent collimated absorbance. 
Once the parameters S and D were known, it became possible to determine ACOLL from 
AICAM.  To determine S and D, the spectrum of metmyoglobin was acquired with and 
without milk as a scattering agent.  The sample with milk was placed in the ICAM, and 
AICAM was acquired (figure 2.5, panel A).  The sample without milk was placed in 
cuvette, and ACOLL was acquired (figure 2.5, panel B). AICAM was plotted against ACOLL 
and the 300 data points were fit to the inverse transfer function, equation 2.2 (figure 2.5, 
panel C).  Finally, S and D were determined using a Monte-Carlo fitting program in 
Graphpad (figure 2.5, panel D):60 
 𝐴𝐴𝐼𝐼𝐶𝐶𝐼𝐼𝐼𝐼 = 𝑆𝑆 ∗ (1 − 𝑒𝑒−𝐷𝐷∗𝐼𝐼𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶). 2.2 
S was 0.938 ± 0.007, and D was 40 ± 0.46 with a standard deviation of 0.0119.  The next 




Figure 2.5: Relating Molar Absorptivity to Molar ICAM Absorptivity  
Measured absorbances in the ICAM were not linearly proportional to molar absorptivity 
and must be transformed to equivalent collimated absorbances.  Metmyoglobin molar 
absorptivities (A) were compared to metmyoglobin molar ICAM absorptivities (B). This 
comparison shows molar ICAM absorptivity did not relate linearly in terms of 
concentration, and did not follow Beer's Law (C).  The inverse transfer function was 
established by comparing ICAM absorbances to collimated absorbance using a constant 
concentration (D).  The data were well-fitted by equation 2.2, 𝑨𝑨𝑰𝑰𝑰𝑰𝑨𝑨𝑰𝑰 = 𝑺𝑺 ∗
(𝟏𝟏 − 𝒆𝒆−𝑫𝑫∗𝑨𝑨𝑰𝑰𝑪𝑪𝑪𝑪𝑪𝑪),  and S was 0.938 ± 0.007 and D was 40 ± 0.46 with a standard deviation 




Validation of Transfer Function using the Spectra of Oxygenated Hemoglobin in the Red 
Blood Cell  
The parameters S and D were validated using oxygenated hemoglobin in the red 
blood cells.  The spectra of oxygenated hemoglobin in the red blood cells were acquired 
with and without light scattering.  A thin-layer of red blood cells does not scatter light 
and was used to obtain ACOLL.  The sample of red blood cells with milk does scatter light 
and was used to obtain AICAM.  The AICAM spectrum was transformed to the ACOLL 
spectrum using S and D from the metmyoglobin fitting.  After normalizing at 576 nm, the 
transformed ACOLL was compared to the non-scattering ACOLL.  The standard deviation 
between them was very low at 0.004, as shown in figure 2.6.  
Validation of Transfer Function using the Spectra of Oxygenated Hemoglobin at 30 µM 
The parameters S and D were validated using dilute oxygenated hemoglobin in 
solution.  The spectra of dilute oxygenated hemoglobin in solution were acquired with 
and without light scattering.  A solution of hemoglobin does not scatter light and was 
used to obtain ACOLL.  The solution of hemoglobin with milk does scatter light and was 
used to obtain AICAM.  The AICAM spectrum was transformed to the ACOLL spectrum using 
S and D from the metmyoglobin fitting.  The transformed ACOLL was then compared to 
the non-scattering ACOLL.  The two ACOLL spectra were scaled to 1 at 576 nm and 
compared.  This comparison fitted with a standard deviation of 0.004, indicating that the 























Figure 2.6: Transformed ICAM Absorbance Overcomes Light Scattering 
The absorbance spectrum of oxyhemoglobin in the red blood cells (black) agreed well 
with the transformed ICAM absorbance spectrum of oxyhemoglobin in the red blood 
cells (green, σ = 0.0045).  The non-transformed ICAM absorbance spectrum of 
oxyhemoglobin in the red blood cells (red) did not agree well with the thin-layer 
absorbance spectrum of oxyhemoglobin in the red blood cells.  This showed that the 
inverse transfer function will transform correctly measured absorbances of turbid samples 
to absorbance, correctly eliminating scattering artifacts.  Spectra were scaled at 576 nm to 




Deoxygenation of Myoglobin: Validation of the Oxygen Electrode  
The oxygen electrode was validated by determining the oxygen-binding constant 
of myoglobin, K, and comparing it to literature values.  The myoglobin oxygen-binding 




1 + 𝐾𝐾 ∗ [𝑂𝑂2]
. 2. 3 
In this equation, 𝑌𝑌 �was the fractional saturation, K was the oxygen-binding 
constant of myoglobin, and [O2] was the oxygen concentration of the solution.  A sample 
of myoglobin was deoxygenated in the ICAM sample chamber.  During the 
deoxygenation process, the oxygen concentration and AICAM at 576 nm was collected.  
AICAM was transformed to ACOLL using the transfer function.   
The parameters A0 and Aꝏ must be acquired before the fractional saturation of 





In this equation, A0 was the absorbance of the myoglobin when none of the oxygen-
binding sites contain oxygen and Aꝏ was the absorbance with 100% of the oxygen-
binding sites contain oxygen.  
Both Aꝏ and A0 were obtained through extrapolation.  A0 was acquired by 
substituting 𝑌𝑌� from equation 2.3 into equation 2.4, giving equation 2.5:   
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1 + 𝐾𝐾 ∗ [𝑂𝑂2]
. 
2.5 
Equation 2.5 was rewritten as equation 2.6:  
 
𝐴𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 =  
𝐾𝐾 ∗ [𝑂𝑂2]
1 + 𝐾𝐾 ∗ [𝑂𝑂2]
∗ (𝐴𝐴ꝏ − 𝐴𝐴0) + 𝐴𝐴0. 
2.6 
As the oxygen concentration approached 0 µM, the left-side of equation 2.6 was 
eliminated, and equation 2.6 was simplified to equation 2.7 at low oxygen concentration: 
 𝐴𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 = 𝐴𝐴0. 2.7 
Therefore, A0 was determined by fitting the lowest 10% absorbances and concentrations 
with a linear line using Graphpad, and A0 was the y-intercept.  Data from 2.5 to 3.0 µM 
was plotted and A0 was 0.00086 ± 0.0002 with 6 data points in the fitting. A0 was also 
confirmed by adding 20 milligrams of sodium dithionite to the deoxygenated solution of 
myoglobin and the absorbance measured.   
Deoxygenation of Myoglobin: Determination of Aꝏ  
Aꝏ was determined through extrapolation of a double-reciprocal plot of equation 
2.5.  The inverse of equation 2.5 gave equation 2.8:  
 𝐴𝐴ꝏ − 𝐴𝐴0
𝐴𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 − 𝐴𝐴0
=

















As the oxygen concentration approaches infinity, then the left side of the equation 










Aꝏ was determined by plotting the top 10% of ACOLL with the corresponding oxygen 
concentrations as 1
𝐼𝐼𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶−𝐼𝐼0
  vs. 1[𝐶𝐶2].  Graphpad fitted the double reciprocal of the ACOLL 
and oxygen concentrations using 18 data points from 180 to 250 µM oxygen.  The y-
intercept was equal to 1
𝐼𝐼ꝏ−𝐼𝐼0
, and A0 was found previously.  
1
𝐼𝐼ꝏ−𝐼𝐼0
 was found to be 246 ± 
6, and Aꝏ was 0.0049. 
Deoxygenation of Myoglobin: Determination of the Myoglobin Oxygen-Binding Constant 
With parameters A0 and Aꝏ elucidated, the fractional saturation, 𝑌𝑌�, could be 





ACOLL was correlated to the oxygen concentration of the solution.  As A0 and Aꝏ were 
constants during the deoxygenation of myoglobin during the experiment, 𝑌𝑌� were 
correlated to given oxygen concentration.  𝑌𝑌� was plotted against the oxygen 
concentration and this allowed the determination of the myoglobin oxygen-binding 




1 + 𝐾𝐾 ∗ [𝑂𝑂2]
. 2. 12 
The myoglobin oxygen-binding constant was experimentally determined as 0.4800 ± 
0.0022 µM-1 with 264 data points agrees well with literature values (0.54 µM-1) under 
similar conditions (fig. 2.7).61,62 
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Spectral Differences of Oxygenated Hemoglobin at 30 µM and Oxygenated Hemoglobin 
in the Red Blood Cell 
The differences between the spectra of oxygenated hemoglobin at 30 µM and 
oxygenated hemoglobin in the red blood cell were plotted on figure 2.8.  The ACOLL 
spectra of oxygenated hemoglobin at 30 µM and the AICAM in the red blood cell was both 
obtained using the ICAM.  The AICAM spectrum was transformed to the ACOLL spectrum 
using S and D from the metmyoglobin fitting.  The two ACOLL spectra were normalized at 
576 nm.  The standard deviation between the two was 0.007, with the lowest correlation 




   
Figure 2.7: Myoglobin Oxygen-Binding Thermodynamics 
𝑌𝑌� =  
𝐾𝐾 ∗ [𝑂𝑂2]
1 + 𝐾𝐾 ∗ [𝑂𝑂2]
. 
Myoglobin oxygen-binding thermodynamics were measured to validate the oxygen 
electrode.  The transformed ICAM absorbance was compared directly to oxygen 
concentration using time as a constant (A).  The transformed ICAM absorbance was 
scaled to fractional saturation by obtaining A0 and Aꝏ from the y-intercepts of panels B 
and C, respectively.  From known A0 and Aꝏ, the fractional saturation for any given 
oxygen concentration can be determined from equation 2.4 (D).  The equilibrium binding 





Overview of ICAM Spectrophotometry Validations 
The results in this chapter demonstrate that it was possible to study the oxygen-
binding thermodynamics of hemoglobin in the red blood cell.  The ICAM 
spectrophotometer raised the signal-to-noise significantly to overcome the very low 
signal-to-noise of the scattered light that accompanies the use of red blood cells.  Solving 
the transfer function allowed for the transformation of the ICAM absorbances (AICAM) 
into collimated absorbances (ACOLL) which were linearly related to concentration.   
Finally, the oxygen electrode was tested by deoxygenating myoglobin.  The validation of 
the transfer function and the oxygen electrode meant the ICAM could be utilized to 
compare the oxygen-binding thermodynamics of the hemoglobin in the red blood cells 
and in dilute solution.  
ICAM Light-Scattering  
The ICAM overcame the light scattering effects of the red blood cells by 
overwhelming the scattering.  The ICAM instrument design had two different scatterers.  
One was the deflector and the other was 1% milk in solution.  Both were necessary for 
the complete light scattering.  Without milk, the experimental design had Mie scattering 
effects, which proved challenging to overcome.  A general-purpose light scattering agent 
was necessary to remove the Mie scattering effects of the red blood cells.  In essence, 
most incident photons entering the ICAM were immediately scattered by the particles, 
and the rest were scattered by the deflector.  The idealized light-scattering agent would be 
roughly the same size as the red blood cell with a similar refractive index to overwhelm 
the effect of light-scattered of the red blood cells.  Several different agents were tested, 
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such as psyllium husk powder, polyvinyl pyrrolidone with an average molecular mass of 
40,000, powdered Milk (Hoosier Hill Farm, 2lbs), and milk.  Milk was chosen as the milk 
fat globules did not require time to dissolve in solution, did not aggregate in solution, and 
was simple to reproduce the exact amount added.  To maintain sterility, the milk was 
used on the day it was opened.   
Selection of a Standard Sample for Determining the Transfer Function Parameters 
A standard sample was needed to establish whether the transfer function was 
capable of transforming AICAM into ACOLL.  Horse heart metmyoglobin was chosen for 
three major reasons.  First, metmyoglobin absorbs across the visible spectrum, and has 4 
different absorption peaks at 500 nm, 542 nm myoglobin, 575m, and 632 nm to ensure 
precision on the wavelength basis.63  The parameters of the transfer function were solved 
using wavelengths from 500 to 650 nm, which ensured the transfer function parameters 
were wavelength-independent.  The second reason metmyoglobin was chosen was that it 
its spectrum is pH-independent.  This ensured that slight pH shifts would not significantly 
perturb AICAM measurements.  The third reason was that a solution of metmyoglobin does 
not scatter light.   
The Transfer Function Parameters S and D 
Parameters S and D were determined by obtaining the spectrum of metmyoglobin 
with and without milk as a scattering agent (AICAM and ACOLL, respectively).  The results 
showed that the ICAM spectrophotometer was more sensitive than the collimated 
spectrophotometer.  The ICAM spectrophotometer has a much longer pathlength because 
the light scatters within the sample chamber.  For instance, the ICAM round-bottom flask 
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has a diameter of 8 centimeters, but the equivalent pathlength of approximately 32 
centimeters.  The increased sensitivity of the ICAM is one of its useful features. 
Transfer Function Validation 
The parameters of the transfer function were validated using a sample that 
scattered light and a sample that did not scatter light.  For the first validation, red blood 
cells were used as the light scattering sample.  The light scattering of a suspension of red 
blood cells comes from the interaction of the cell membrane with the intercellular buffer, 
which has a different index of refraction.  As the amplitude of visible light is smaller than 
the cells, light scatters as it interacts with the cell membrane, and a solution of red blood 
cells is opaque.  Parkhurst showed that packed red blood cells did not scatter light, as 
little buffer remained on the outside of the cells.64  The difference in the index of 
refraction is removed in a packed thin-layer of red blood cells, and this method 
determined the ACOLL of oxygenated hemoglobin in the red blood cells by collimated 
spectrophotometry.  The ACOLL spectrum was also determined using the ICAM and the 
transfer function.  Both ACOLL spectra were compared and agreed well. For the second 
validation, the non-scattering solution used was hemoglobin in solution.  The ACOLL 
spectra determined from the ICAM and from collimated spectrophotometry were 
compared and agreed well (fig. 2.6).  This showed the parameters of the transfer function 
were well determined for both scattering and non-scattering solutions.  Interestingly, the 
spectra of oxygenated hemoglobin in solution differed from the spectra of oxygenated 
hemoglobin in the red blood cell (fig. 2.8).  Spectral changes indicated a chemical 
difference!   
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Deoxygenation of Myoglobin 
The oxygen electrode and the deoxygenation of the ICAM were tested by 
deoxygenating reduced horse heart myoglobin while monitoring both the absorbance 
changes and the oxygen concentration in solution.  Myoglobin was chosen for three 
reasons.  First, the fractional determination can be determined from absorbance 
measurements.  Second, it is a monomer which required fitting only one thermodynamic 
parameter.  Third, there were no dimerization complications to consider.  The myoglobin 
oxygen-binding constant determined from the ICAM spectrophotometry was 0.4800 ± 
0.0022 µM-1, and the literature value was 0.54 µM-1.65  This validated the oxygen 
electrode.  With the transfer function and oxygen electrode verified, we determined the 
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Figure 2.8: The Spectrum of Oxygenated Hemoglobin at Two Different 
Concentrations 
The spectra of oxygenated hemoglobin in the red blood cell and in solution fit with a 
standard deviation of 0.007 and did not agree well.  The spectral differences in the 510 




3. Oxygen-Binding of Hemoglobin in Solution Compared to Hemoglobin within 
the Red Blood Cells at 18°C 
3.1 Introduction 
Contrasting Thermodynamic Models to Physiological Observations 
 The study of hemoglobin oxygen-binding thermodynamics depends on fitting the 
oxygen-binding curve to a thermodynamic model based on physiological observations.  
These fits elucidated further chemical information from the parameters determined from 
the models.  The thermodynamic models of hemoglobin oxygen-binding fall into two 
categories: the sequential models and the concerted models.  Sequential models, such as 
the Adair and KNF models, assume that each oxygen binding event has a different 
affinity.  Cooperative oxygen binding occurs because the affinity increases as more 
oxygen sites become filled. In contrast, the concerted MWC model assumes that there are 
two hemoglobin conformational states and that each of those states has a fixed oxygen-
binding affinity.  In concerted models, cooperativity occurs because the binding of 
oxygen drives a conformation change from the low-oxygen-affinity state to the high-
oxygen-affinity state.   
Adair Model: Sequential Mechanism 
In 1924, Adair's dialysis experiments determined that hemoglobin consisted of 
four subunits with four oxygen-binding sites.66,67  With the number of binding-sites 
elucidated, Adair derived an equation for determining the fractional saturation.  Each of 
the oxygen-binding sites were considered chemically equivalent.  Further gasometric 
measurements by Adair and others were the first attempts to determine thermodynamic 
constants for hemoglobin.66,67 K1 was the parameter for hemoglobin binding a single 
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oxygen molecule, K2 was the parameter for hemoglobin binding the second oxygen 
molecule, and likewise up to K4.  The oxygen-binding thermodynamics were determined 






𝐾𝐾𝐼𝐼[𝑂𝑂2] + 2𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + 3𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 + 4𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4
1 + 𝐾𝐾1[𝑂𝑂2] + 𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + 𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 + 𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4
. 
3.1 
where 𝑌𝑌� is the fractional saturation, the numerator is the number of oxygen-binding sites 
liganded, and the denominator is the total number of oxygen-binding sites.     
 This model is fundamental.  However, it has proven to be exceedingly difficult to 
obtain fits for all the binding constants.  In particular, K3 is always very small, is 
associated with negative cooperativity, and typically has a standard deviation of 25-
50%.32,61,68  In general, this shows that the saturating oxygen conditions are most difficult 
to fit with the Adair model.69  Various mathematical and experimental attempts have been 
made to resolve the error in K3, with varying levels of success.   
KNF Model: Sequential Mechanism 
 Developed by Koshland, Nemethy, and Filmer in 1966, the KNF model supposes 
that the transition from the deoxygenated and oxygenated conformations happens at the 
tertiary level.69  This model argues that the two conformations observed through x-ray 
crystallography do not allow for conformational changes of the monomers.  In this 
model, the protein conformation changes with each binding of ligand, thus sequentially 
changing its affinity for oxygen at the other binding-sites.  The monomers undergo 
independent conformational changes, but the change of one monomer affects the others.  
The number of hypothetical hemoglobin conformations ranges from five to sixteen.  We 
did not use the KNF model for three key reasons.  First, the model does not fit 
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hemoglobin well from 𝑌𝑌� ranges below 0.025 and above 0.975, where considerable 
thermodynamic information can be elucidated.70  Second, there is limited structural 
evidence of more than two conformational states of the tetramer.  Third, there is limited 
thermodynamic evidence of more than two hemoglobin conformations in physiological 
conditions.  We used a thermodynamic model based on physiological observations, the 
MWC model. 
MWC Model: Concerted Mechanism 
 In 1965, Monod, Wyman & Changeux proposed an allosteric model that 
comprehensively interpreted both the homotropic and hetereotropic effects of regulatory 
enzymes in terms of certain features of protein structure.62  The model utilized five basic 
assumptions: 
1) Allosteric proteins are polymers in which the monomers are experimentally 
equivalent. 
2) Each monomer carries one binding site for each ligand bound.  Each set of 
binding sites has the same symmetry. 
3) Ligand binding of one monomer imposes constraints on the conformation of 
each of them 
4) The protein is in an equilibrium between at least two alternative quaternary 
structures which differ by distribution and energy of inter-subunit bonds and 
consequently by ligand affinity for each of the binding sites.  
5) When the protein goes from one state to another, its molecular symmetry is 
conserved.   
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In the case of hemoglobin, it is assumed the four monomers are chemically 
identical and there are two conformations based on structural data.  The two 
conformations are the oxygenated quaternary conformation, the R-state, and the 
deoxygenated quaternary conformation, the T-state.  T0,T1,T2,T3,T4 and R0,R1,R2,R3,R4 
represent zero, one, two, three and four oxygens bound the T-state and R-state, 
respectively.  The T-state is in equilibrium with the R-state with equivalent oxygens 
bound, and the parameter L is the equilibrium between T0 and R0.  The parameters KT and 
KR are the association constants for the T-state and R-state respectively.  KT and KR are 
constant no matter the number of oxygens bound to the T-state and R-state, respectively.  
Due to this symmetry, an oxygen-binding fit can be derived from two conformations 
using three different parameters, L, KT, and KR.   
 
𝑌𝑌� =
𝐿𝐿 · 𝐾𝐾𝑇𝑇 · [𝑂𝑂2] · (1 + 𝐾𝐾𝑇𝑇 · [𝑂𝑂2])3 + 𝐾𝐾𝑅𝑅 · [𝑂𝑂2] · (1 + 𝐾𝐾𝑅𝑅 · [𝑂𝑂2])3
𝐿𝐿 · (1 + 𝐾𝐾𝑇𝑇 · [𝑂𝑂2])4 + (1 + 𝐾𝐾𝑅𝑅 · [𝑂𝑂2])4
. 
3.2 
 The MWC model has strong experimental evidence.  Both the T-state and R-state 
have been elucidated with x-ray crystallography and other techniques.  There are a 
maximum of three conformations based on kinetic, thermodynamic, and structural data.  
Considering the experimental evidence and the fitting, this was the model chosen to fit 
the data in our study.  
Hill Equation & Cooperativity 
Hemoglobin is an example of a cooperative protein because the binding of one 
oxygen molecule increases the affinity for subsequent oxygen molecules.  The utility of 
the Hill equation lies in its simplicity, and this is why it is ubiquitous across hemoglobin 
oxygen-binding experiments.  It is a mathematical fit independent of the 
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thermodynamical model.  A measure of the overall cooperativity is often presented by the 









The Hill number, nH, is determined at a fractional saturation of 0.5.  𝑌𝑌� is the fractional 
saturation, and [O2] is the oxygen concentration.  Under physiological conditions, the Hill 
number for hemoglobin in solution is 2.7-3.0. 
3.2 Materials and Methods 
Data Acquisition: Deoxygenation of Hemoglobin in Red Blood Cells (HBRBC) and 
Hemoglobin in Dilute Solution (HBSOLN) 
Two different samples were deoxygenated in the ICAM, the hemoglobin in 
solution (HBSOLN) and the hemoglobin in the red blood cell (HBRBC).  To study HBSOLN, 
8.170 mL of 4.890 mM hemoglobin (heme basis) in deionized water were added to the 
ICAM after blanking the ICAM spectrophotometer as discussed in “Chapter 2: Materials 
& Methods.”  During a separate run, 600 µL of 50% hematocrit red blood cells 
suspended in 1% (w/v) NaCl in 100 mM phosphate buffer at pH 7.4 were added to a 
blank ICAM to study HBRBC.  Both solutions contained 4 milligrams of superoxide 
dismutase (Sigma) and 20 milligrams of catalase (Thermo Fisher Scientific), which 
removed any autooxidation of hemoglobin by superoxide.  During both experiments, the 
solution was deoxygenated at 18°C (see Control of ICAM Solution deoxygenation 
through gentle nitrogen airflow from chapter 2).  AICAM measurements were recorded 
every second.  At the same time, oxygen electrode readings were measured from the YSI 
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5300 control panel every 20 seconds.  The AICAM was smoothed against time through a 
23-window Savitsky-Golay filter and the oxygen concentration data points were 
LOWESS-fitted to estimate the oxygen concentration at every second.  After 
deoxygenating both solutions by passing water-saturated nitrogen gas over the solution, 
20 milligrams of sodium dithionite was added to ensure complete deoxygenation.  During 
the deoxygenation of HBSOLN, 30960 ACOLL measurements at 670 nm and 1548 oxygen 
electrode measurements were collected.  During the deoxygenation of HBRBC, 14058 
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Figure 3.1: Oxygen-Binding Thermodynamics of Hemoglobin Determined by The Relationship between Absorbance and 
Oxygen Concentration  
The oxygen-binding thermodynamics of hemoglobin can be determined from absorbance and oxygen concentration changes during 
deoxygenation of the hemoglobin.  A is the absorbance and oxygen concentration changes over the course of an experiment at constant 
temperature, and B is the direct relationship between absorbance and oxygen concentration as a function of time.  A small change at 






Deoxygenation of Hemoglobin in Red Blood Cells & Hemoglobin in Solution: Fractional 
Saturation 
During the deoxygenation of hemoglobin in red blood cells (HBRBC) and 
hemoglobin in solution (HBSOLN) in the ICAM spectrophotometer, the AICAM and the 
corresponding oxygen measurements were obtained.  The AICAM was transformed to 
ACOLL using the transfer function described in chapter 2, and the oxygen measurements 
were converted to oxygen concentration using methods described in chapter 2 and 
appendix 5.6.  The oxygen-binding curve required the fractional saturation to be acquired 
from the ACOLL and oxygen concentration.  The fractional saturation of hemoglobin is the 
percent of hemoglobin oxygen-binding sites bound with oxygen.  The fractional 
saturation of hemoglobin, 𝑌𝑌� , for any given oxygen concentration at 620 nm was 




. 3.4  
Similarly to chapter 2, 𝑌𝑌�, the fractional saturation, was defined with three 
different parameters: A0 was the absorbance of the myoglobin when none of the oxygen-
binding sites contain oxygen, Aꝏ was the absorbance with 100% of the oxygen-binding 
sites contain oxygen, and ACOLL was the absorbance measurement at any given oxygen 
concentration.  A0 was greater than Aꝏ for any wavelength greater than 585.9 nm, and 
thus equation 3.4 was different than equation 2.4.  Both parameters A0 and Aꝏ must be 
ascertained before the fractional saturation of hemoglobin can be determined. 
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Deoxygenation of HBRBC & HBSOLN: Determination of A0: 
Both Aꝏ and A0 were found through extrapolation.  The Adair equation was used 
to determine Aꝏ and A0 because the MWC model does not lend itself as well to this task.  
To begin, 𝑌𝑌�  in the Adair relationship (equation 3.4) and in the fractional saturation 
relationship (equation 3.1) were combined with to obtain equation 3.5:   






𝐾𝐾𝐼𝐼[𝑂𝑂2] + 2𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + 3𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 + 4𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4
1 + 𝐾𝐾1[𝑂𝑂2] + 𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + 𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 + 𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4
. 3.5 
 






𝐾𝐾𝐼𝐼[𝑂𝑂2] + 2𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + ⋯
1 + 𝐾𝐾1[𝑂𝑂2] + 𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + ⋯
· (𝐴𝐴0 − 𝐴𝐴ꝏ) + 𝐴𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 . 
3.6 
Thus, as the oxygen concentration approaches 0 µM, the cubic and quartic 
portions of the binding polynomial are greatly diminished, and equation 3.6 reduces to 
equation 3.7: 
 𝐴𝐴0 = 𝐴𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶. 3.7 
Therefore, A0 can be determined by fitting 5186 ACOLL measurements with a quadratic 
polynomial to find the y-intercept.  In the case of HBSOLN, A0 was determined to be 
0.0719 ± 0.00004.  Similarly, A0 for deoxygenation of HBRBC was determined to be 
0.00875 ± 0.00001 (fig. 3.2) using 4779 ACOLL measurements.  These results were 
confirmed by adding 20.0 mg of sodium dithionite to ensure complete deoxygenation.  
Deoxygenation of HBRBC & HBSOLN: Determination of Aꝏ 
Aꝏ was also determined through extrapolation.  In this case, a reciprocal plot of 
equation 3.6 gave equation 3.8:  
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 𝐴𝐴0 − 𝐴𝐴ꝏ
𝐴𝐴0 − 𝐴𝐴𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
= 4 ∗
1 + 𝐾𝐾1[𝑂𝑂2] + 𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + 𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 + 𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4
𝐾𝐾𝐼𝐼[𝑂𝑂2] + 2𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 + 3𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 + 4𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4
. 3.8 




1 +𝐾𝐾1[𝑂𝑂2] + 𝐾𝐾1𝐾𝐾2[𝑂𝑂2]2 +𝐾𝐾1𝐾𝐾2𝐾𝐾3[𝑂𝑂2]3 +𝐾𝐾1𝐾𝐾2𝐾𝐾3𝐾𝐾4[𝑂𝑂2]4





As the oxygen concentration approached infinity, the equation further simplified 











Extrapolation to infinite concentration caused the left-hand side of the equation to 






. 3.11  
 
Therefore, Aꝏ was determined by plotting the highest 10% of absorbances as 
1
𝐼𝐼0−𝐼𝐼𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
  vs. 1[𝐶𝐶2].  The y-intercept was equal to 
1
𝐼𝐼ꝏ−𝐼𝐼0
, and A0 was found previously.  The 
Aꝏ of the deoxygenation of HBSOLN was determined from 3030 data points ranging from 
112-213 µM, and Aꝏ was 0.00076 ± 0.000004.  The Aꝏ of the deoxygenation of HBRBC 
was determined from 3030 data points ranging from 70-259 µM, and Aꝏ was 0.00135 ± 
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Figure 3.2: Determining the Fractional Saturation from Absorbance and Oxygen 
Concentration 
The fractional saturation of hemoglobin was the percent oxygen bound and was linearly 
related to absorbance.  The scaling of fractional saturation is 0 to 1, where 0 is 0% 
oxygen bound to hemoglobin at absorbance A0, and 1 is 100% oxygen bound to 
hemoglobin at absorbance Aꝏ.  A0 is the y-intercept of a quadratic equation fitting at the 
lowest 10% of absorbance, in this case 0-10 O2 µM (A).  Aꝏ is the inverse y-intercept of 
a linear fit of a double-reciprocal plot of the top 5% of absorbance (B).  The fractional 
saturation of hemoglobin (𝑌𝑌�) can be determined using 𝑌𝑌� = 𝐼𝐼0−𝐼𝐼𝑋𝑋
𝐼𝐼0−𝐼𝐼ꝏ




MWC & Hill Slope Fitting 
 The oxygen-binding curves were plotted by comparing the fractional saturation 𝑌𝑌� 
to the oxygen concentration for both solutions, HBSOLN and HBRBC.  The MWC 
parameters of the oxygen-binding curves were determined using OriginPro 2020b.  KR, 
KT and L were found by Levenberg-Marquardt iterations of equation 3.2 to the oxygen 
binding curves.  The results of the fittings are listed on table 3.1. 
 The Hill coefficient nH, a common measure of cooperativity, was found by 
plotting log [𝐶𝐶2]
1−[𝐶𝐶2]
 against log 𝑌𝑌�and finding the maximal slope, which is when 𝑌𝑌� is 0.5.   
 
Table 3.1: Hemoglobin Oxygen-Binding Parameters in Solution and in the RBC 
(18°C) 
 
Parameter Hemoglobin in RBC Hemoglobin in Solution Difference (%) 
nH 2.475  ± 0.2% 2.949  ± 0.1% 16 
𝑋𝑋� (µM) 15.17  ± 0.1% 18.83 ± 0.1% 30 
L 870  ± 1.0 % 9830 ± 1.4% 91 
KR (µM-1) 0.353 ± 0.3% 0.532 ± 0.4% 33 





Comparison of the Hemoglobin Oxygen-Binding Parameters in Solution and in the RBC 
at 18°C 
All of the hemoglobin oxygen-binding parameters of hemoglobin were different 
in RBC (HBRBC) versus in solution (HBSOLN).  First, the Hill number was 16% smaller in 
RBCs, indicating that HBRBC releases oxygen to the tissues over a wider concentration 
than would be predicted from HBSOLN measurements.  𝑋𝑋� is the oxygen activity at half-
saturation, a measure of oxygen affinity.  In the red blood cells,  𝑋𝑋� is 30% lower than in 
solution. This indicated that oxygen is released at lower concentrations that would be 
predicted from solution measurements.  
The differences between HBSOLN to HBRBC were even larger for the three 
parameters of the MWC model.  The largest difference was in the parameter L that 
differed by 91%.  Since L is the ratio of oxygen-free T-state hemoglobin divided by 
oxygen-free R-state hemoglobin, the difference indicates that HBRBC favors the T-state. 
The KR value for HBRBC is smaller by 33% than in solution indicating stronger oxygen 
affinity of the R-state. In contrast, KT is the only value that increases in RBCs compared 
to solution. The oxygen affinity of the expanded deoxygenated T-states was 24% higher 
in RBCs, indicating that HBRBC bound oxygen considerably weaker than in solution.  
The differences between the HBRBC and HBSOLN oxygen binding curves are 
correlated with spectral differences of oxygenated hemoglobin in the RBC and in 
solution. The major differences are in the oxygenated spectra.  The 576/560 nm ratios for 
oxyhemoglobin in the erythrocyte and in solution are 1.42 and 1.63, respectively.  These 
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differences between cellular hemoglobin and solution hemoglobin reflect the 
environmental dependence of the relaxed conformations.  
3.4 Discussion 
We have validated the components of our system in several ways. One of the 
most relevant is that our binding parameters for hemoglobin in solution are in very good 
agreement with literature values.  Published values for the three MWC parameters, L, KR, 
and KT were 9100, 0.532 µM-1, and 0.0069 µM-1, respectively.62  We report values of 
9480, 0.532 µM-1, and 0.0061 µM-1, respectively (table 3.1).  When curves are generated 
using these two sets of values, the standard deviation of the fit is very small at 0.0028 
(fig. 3.3).  
Our binding parameters for hemoglobin in red blood cells shows that 
encapsulation within the RBC results in significantly lowered co-operativity and higher 
oxygen affinity than in solution (fig. 3.4). First, the lowered cooperativity of HBRBC 
compared to HBSOLN is established by our nH values of 2.475 and 2.976, respectively. 
Literature values are in the same range as ours but not nearly as precise. Multiple 
gasometric studies of hemoglobin-oxygen binding in the RBC have reported Hill 
numbers ranging from 2.5 to 3.3.32,67,71–73   Recently, transient absorption microscopy was 
used to study oxygen binding in a single red blood cell.74  Only six data points were 
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Figure 3.3: Hemoglobin Oxygen-Binding Compared to Literature 
The fits of the hemoglobin in solution discussed in this chapter were plotted against 
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Figure 3.4: Difference of Hemoglobin Oxygen-Binding in Different Environments 
Hemoglobin in the red blood cell showed greater affinity for oxygen than hemoglobin in 
solution with less co-operativity.    
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The increased affinity of HBRBC is demonstrated by our reported affinity of 15.63 
µM compared to our reported affinity of 18.83 µM for HBSOLN.  Our HBSOLN affinity is 
similar to values reported in the literature.32,72,73  The closest equivalent for our HBRBC 
measurements is a thin-layer study that yielded half-saturation values for oxygenated 
HBRBC in good agreement with the values reported herein.75 However, that study did not 
make a direct comparison with hemoglobin free in solution. 
Deeper mechanistic insights were obtained by elucidating the MWC parameters 
for HBRBC and HBSOLN.  The largest difference, 92%, was for L, the ratio of the T- to R-
state populations in the absence of oxygen. L was 870 in the red blood cell and 9830 
when free in solution. This dramatic decrease in the population of the lower-affinity 
structure in the red blood cell explains in part its higher oxygen affinity.  
The relative binding constants also support the observation of higher affinity in 
the red blood cell. Specifically, the binding constant, KR, for HBRBC is approximately 
24% greater than in solution. Likewise, KT for HBRBC is a 43% greater than in solution. 
Taken together, these parameters indicate higher affinity of the hemoglobin molecule for 
oxygen when packed in the erythrocyte.  These differences are seen in the left-shifted 
oxygen binding curve of HBRBC compared to that of free hemoglobin (fig. 3.4).  The few 
studies that have measured these MWC parameters in red blood cells have not made 
direct comparison with hemoglobin free in solution. Of those, one thin-layer study 
reported thermodynamic parameters at 37°C and pH 7.4 that were associated with very 
large uncertainties.74  As a result, their reported KT  and calculated KR values overlap 
within error, and is consistent with no T-state to R-state conformational change upon 
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oxygenation. Such a finding conflicts with our basic understanding of hemoglobin. Also 
in that paper, L was 16 million, a dramatically different value from that of 870 reported 
herein.   
The concentration of hemoglobin in red blood cells is 23-24 mM, more than half 
of the concentration in the crystal.  In contrast, solution measurements of hemoglobin 
typically use about 100 µM to obtain precise data and to prevent dissociation into non-
cooperative dimers.  We suggest that this approximately 250-fold difference between the 
concentrations of hemoglobin in solution and in erythrocytes gives rise to significantly 
different molecular behavior.  The higher affinity of the confined hemoglobin must be 
related to the close proximity of the hemoglobin in the red blood cell, as supported by the 
differences in the absorbance spectra in both environments.  The difference is 
significantly greater for the oxy spectra, which is primarily R-state hemoglobin. We 
postulate that the R-state conformation in the erythrocyte that is altered relative to both 
the crystal and solution structures. 
The long-held assumption that the binding and release of O2 from HBSOLN is the 
same as HBRBC is disputed by results presented herein.  The behavior of hemoglobin in its 
natural cellular environment is significantly different.  From a physiological perspective, 
the variable demands of the plethora of organs and tissues in the human body are better 
satisfied with a less cooperative release of oxygen from hemoglobin.  We find that the 
encapsulated, packed hemoglobin unloads its oxygen in a more evenly distributed process 




4. Comparison of Thermodynamics of Oxygen-Binding of Hemoglobin in 
Solution versus Hemoglobin in the Red Blood Cell 
4.1 Introduction 
The cooperativity of hemoglobin has been described as a “molecular lung in reverse,” 
decreasing in size as the deoxygenated T-state hemoglobin binds oxygen and undergoes a 
conformation changes to the compacted R-state.  The T-state hemoglobin is called the 
tense-state of hemoglobin due to a series of salt bridges that lock different helices in 
place, as described in chapter 1.  As T-state hemoglobin binds oxygen, the salt bridges are 
broken and entropy increases as the hemoglobin adopts a relaxed conformation, or the R-
state.  While hemoglobin binding oxygen is exothermic and exergonic under 
physiological conditions, much experimental evidence shows that the thermodynamic 
driving-force for HBSOLN was the large increase of energy during the transition from T-
state to R-state.   
Detailed thermodynamic information about the transition between T-state to R-state 
hemoglobin can be determined from the binding isotherms of hemoglobin in solution 
(HBSOLN) and hemoglobin in the red blood cell (HBRBC).  The Gibbs free energy (ΔG), 
the enthalpy (ΔH), and the entropy (ΔS) can be determined for each MWC parameter, KR, 
KT, and L, by determining the oxygen-binding curves of HBSOLN and HBRBC of different 
isotherms. By keeping the temperature constant and determining the KR, KT and L of 
equation 3.2, the ΔG of each parameter for each determined temperature can be solved by 
equation 4.1. 
 𝛥𝛥𝛥𝛥 = −𝑅𝑅𝑅𝑅 · 𝐿𝐿𝑛𝑛 𝐾𝐾𝑒𝑒𝑒𝑒 . 4.1 
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In this equation, R is the gas constant 1.987 cal·K-1·mol-1, T is the temperature in 
Kelvin, and Keq is the thermodynamic parameter.  The Gibbs free energy equation 4.2 
relates the enthalpy and entropy to the Gibbs free energy. 
 𝛥𝛥𝛥𝛥 = 𝛥𝛥𝑛𝑛 − 𝑅𝑅 · 𝛥𝛥𝑆𝑆. 4.2 
By combining equations 4.1 and 4.2 using 𝛥𝛥𝛥𝛥 and rewriting, equation 4.3 can be 
determined: 
 𝐿𝐿𝑛𝑛 𝐾𝐾𝑒𝑒𝑒𝑒 = −
𝛥𝛥𝑛𝑛
𝑅𝑅 · 𝑅𝑅
+ 𝛥𝛥𝑆𝑆. 4.3 
Assuming that the heat capacity and entropy of the parameter remain constant, the 
equation can be modified to fit the equilibrium constants of the same reaction at two 













� + 𝛥𝛥𝑆𝑆. 4.4 
In equation 4.4, K1 as the equilibrium constant for the reaction at temperature T1, and K2 
is the equilibrium constant for the reaction at temperature T2.  From this derivation, 
equation 4.4 can be applied to multiple temperatures with multiple equilibrium constants 
by using equation 4.5: 
 





This equation states that the enthalpy is the slope of a linear fit of the Ln Keq plotted 
against inverse temperature (in Kelvin).  The enthalpy and Gibbs free energy for KR, KT, 
L and 𝑋𝑋� can be determined from equations 4.1 and 4.4, and utilizing those values, the 
entropy can be determined from equation 4.2.  From the ΔH, ΔS, and ΔG of the 
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thermodynamic parameters of KR, KT, L and 𝑋𝑋� of HBRBC and HBSOLN, insights into the 
energy that drives the hemoglobin oxygen-binding reaction can be elucidated.  
4.2 Materials and Methods 
Data Acquisition: Deoxygenation of Hemoglobin in the Red Blood Cell and Hemoglobin 
in Solution at Varying Temperatures  
 AICAM and oxygen concentrations were obtained during the deoxygenation of 
HBRBC and HBSOLN at varying temperatures.  The protocols, concentrations, and 
measurements were described in chapter 3.  Hemoglobin in the red blood cells were 
deoxygenated at 18, 20, 26, 32, and 37 °C, and hemoglobin in solution was deoxygenated 
at 14, 18, 20, and 25 °C.  The temperature was maintained using temperature-controlled 
water flowing through Tygon tubing.  The temperature was maintained at ± 0.1 °C during 
the deoxygenation.  Each deoxygenation took place over the course of 4 to 8 hours.  
AICAM was collected every second and oxygen electrode measurements were taken every 
20 seconds.  As previously described, AICAM was transformed to ACOLL, and the oxygen 
electrode measurements for every second was extrapolated.  
Deoxygenation of HBRBC & HBSOLN: Determination of A0, Aꝏ, Cooperativity, and 
Thermodynamic Parameters 
 The determination of the asymptotes, cooperativity, and thermodynamic 
parameters for the deoxygenation of HBRBC and HBSOLN are fully described in chapter 3 
(fig. 3.1).  A0 was found through extrapolation of the plots of ACOLL versus oxygen 
concentration and Aꝏ was determined from the extrapolation of the double reciprocal of 
the same plot.  The MWC parameters KR, KT, and L were found in OriginPro 2020b using 
Levenberg-Marquardt iterations.   
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Deoxygenation of HBRBC & HBSOLN: Determination of Enthalpy, Entropy, and Gibbs Free 
Energy of KR, KT, and L 
 The ΔH for KR, KT, and L, were determined from a linear fit of Ln (Keq) versus T-1 
plot.  The slope of the fit was −𝛥𝛥𝛥𝛥
𝑅𝑅
 as described by equations 4.3, 4.4 and 4.5, and no 
abnormal heat capacities were found (fig. 4.2-4.4).  ΔG of each thermodynamic 
parameter was found from equation 4.1.  ΔS was found by using known parameters ΔH 
and ΔG in equation 4.2.  ΔG was determined from equation 4.1 after obtaining ΔG and 
ΔS.   
4.3 Results 
To determine the thermodynamics of the hemoglobin-oxygen equilibrium, the 
oxygen binding isotherms were obtained at several different temperatures (fig. 4.1 and 
4.2).  The HBRBC experiments were carried out at five temperatures ranging from 18 to 37 
°C (fig. 4.1).  These temperatures were chosen to cover a range of near physiological.  
The HBSOLN experiments were carried out at only four temperatures ranging from 13 to 
25 °C (fig. 4.2).  The experiment could not be carried out at 37 °C because hemoglobin 
tetramers dissociate to dimers precipitated over the time course of the experiment. 
There were significant differences in the temperature dependence of oxygen-
binding affinity for HBRBC and HBSOLN.  For instance, 𝑋𝑋�, the oxygen concentration of the 
solution at the half-saturation of hemoglobin, for HBRBC increased 1.51-fold (from 15.17 
to 22.86 µM oxygen) as the temperature was increased from 18 to 26 °C.  In contrast, the 
𝑋𝑋� for HBSOLN increased 2.45-fold (from 11.75 to 28.90 µM oxygen) over almost the same 
temperature range (from 18 to 25 °C).  When the isotherms were fit using a hyperbolic 
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equation that assumes a single-binding site and no cooperativity, there were much larger 
fitting errors of 14.4% (appendix 5.4).   
To gain mechanistic insights about the energetics of the hemoglobin-oxygen 
equilibrium, the oxygen binding curves in figures 4.1 and 4.2 were fitted to the MWC 
model and the resulting three parameters were analyzed using a van’t Hoff plot (figs. 4.3, 
4.4, and 4.5).  The slope of the plot for L (slope = -∆HL/R) was negative for both HBSOLN 
and HBRBC (figure 4.3).  This indicated that heat was absorbed when hemoglobin made 
the transition from its low-affinity T-state to its high-affinity R-state in the absence of 
bound oxygen.  More important is that the magnitudes of the slopes were very different.  
About three times more enthalpic heat was required in the red blood cell (∆HL = 10.4 
kcal/mol) than in solution (∆HL = 3.2 kcal/mol).  Significantly more energy was needed 
to make the conformational transition in the red blood cell.  The entropic energy 
differences (y-intercepts = ∆SL/R) between the two systems were 50.8 cal/mol•K in red 
blood cells and 29.5 in solution.  This 1.7-fold larger entropic energy indicated 
significantly more order (or, fewer microstates) was involved in the conformational 
transition within the cells than in solution. 
The slopes of the van’t Hoff plots for KT and KR were all positive, indicating that 
energy was released by oxygen bound to either state.  The nearly overlapping lines of the 
KT van’t Hoff plots indicated only minor differences between the two systems (fig. 4.4).  
The enthalpies for oxyhemoglobin formation in the low-affinity T-state were -4.5 
kcal/mol in red blood cells and -3.6 kcal/mol in solution.  The entropies showed slightly 
larger differences at -25.3 cal/(mol·K) in red blood cells and -22.6 cal/(mol·K) in 
solution. The differences were much greater for KR. 
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The slopes of the van’t Hoff plots for KR in the two systems gave enthalpies of -
5.2 kcal/mol in red blood cells and -11.5 kcal/mol in solution (fig. 4.5).  This nearly two-
fold difference indicated that more heat energy is released when oxygen binds to R-state 
hemoglobin in solution than it does in the cell.  An even more profound difference was 
observed for the entropies, in which a change of sign was observed. In red blood cells, 
the entropy associated with KR was – 20.1 cal/(mol·K).  In contrast, that parameter was –
40.6 cal/(mol·K) in solution.  It seems that R-state hemoglobin loses order when it binds 
oxygen in red blood cells, but gains order in solution.  The thermodynamic differences 
between the ratios of 𝐾𝐾𝑇𝑇
𝐾𝐾𝑅𝑅
 for HBRBC and HBSOLN was most adequately described as 






Figure 4.1: Oxygen-Binding Curves of HBRBC at Different Temperatures 
The oxygen-binding curves at 18, 20, 26, 32, and 37 °C of HBRBC are shown here from A-E, respectively.  The oxygen-binding 
affinity decreases at the temperature increases, shown in F.  The data is shown as the black dots and the blue line is the fit using eq. 







Figure 4.2: Oxygen Binding Curves of Hemoglobin in Solution  
The oxygen-binding curves at 13, 18, 20, and 25 °C are shown here from A-E, respectively.  The oxygen-binding affinity decreases at 
the temperature increases, shown in F.  The data is shown as the black dots, the blue line is the fit using eq. 3.2 (MWC binding 
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Figure 4.3: Van’t Hoff Plots for L 
The natural log L values obtained from the data shown in figure 4.1 for HBRBC (in black) 
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Figure 4.3: Van’t Hoff Plots for KT  
The natural log KT values obtained from the data shown in figure 4.1 for HBRBC (in 
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Figure 4.5: Van’t Hoff Plots for KR  
The natural log KR values obtained from the data shown in figure 4.1 for HBRBC (in 





Table 4.1: Oxygen-Binding Thermodynamic Parameters  
Thermodynamic 
Parameter 
HBRBC HBSOLN  Myoglobin in Solution  
ΔGL (20°C) (kcal/mol) -4.1 ± 1.8% -5.4 ±   1.8%  
ΔGKT (20°C) (kcal/mol) -5.1 ± 0.3% -5.0 ±   0.4%  
ΔGKR (20°C) (kcal/mol) -7.4 ± 0.4% -7.6 ±   0.4% ΔG = -7.6 
    
ΔHL (kcal/mol) 10.7 ± 9.6% 3.3 ±   8.7%  
ΔHKT (kcal/mol) -4.5 ± 4.6% -3.6 ± 26.6%  
ΔHKR (kcal/mol) -5.2 ± 4.0% -11.5 ± 11.3% ΔH = -13.5  
    
ΔSL (cal/mol·K)  50.8 ± 4.6% 29.5 ±   3.3%  
ΔSKT (cal/mol·K)  -25.3 ± 2.1% -22.6 ± 14.7%  
ΔSKR (cal/mol·K)  -20.1 ± 3.5% -40.6 ± 11.1% ΔS = -18  
The hemoglobin values were obtained from van’t Hoff plots in figures 4.3, 4,4, and 4.5. 





The results in this chapter indicate that there are significant differences in the oxygen-
binding affinity and cooperativity of HBRBC and HBSOLN. These differences are best 
described by differences in the MWC parameters KR and L. The parameter KT showed 
little difference between the two.  Similarly, the oxygenated R-state of HBRBC and 
HBSOLN had starkly different spectra, whereas the deoxygenated T-state of HBRBC and 
HBSOLN had similar spectra.  The different spectra and thermodynamic values for ΔHKR, 
ΔGKR, and ΔSKR indicated that the R-state chemistry differed between HBRBC and 
HBSOLN.   
The global allostery model of hemoglobin put forward by Imai provides an 
explanation how hemoglobin can have different properties in solution versus in the red 
blood cell. Imai hypothesizes that there is an ensemble of minor conformational states 
within the R-state that result in the different oxygen-binding thermodynamics of the R-
state.  These minor conformational states depend on conditions such as proton 
concentration, salt type and concentration, and the type and concentration of the allosteric 
effector (2,3-diphosphoglycerate, inositol, or others).  The experiments described in this 
chapter add to this list by revealing that encapsulating hemoglobin in red blood cells, 
HBRBC, primarily affects the R-state.   
The values we obtained for the oxygen-binding parameter KR are similar to 
myoglobin single-site thermodynamics in the literature.  Reported values for myoglobin 
oxygen-binding ΔH, ΔG, and ΔS were -13.5 kcal/mol, -7.6 kcal/mol (20°C), and -18 
cal/(mol·K), respectively.  Our HBSOLN R-state ΔH, ΔG, and ΔS were similar at -11.5 
kcal/mol, -7.6 kcal/mol, and -40.6 cal/(mol·K).  In contrast, our HBRBC R-state 
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parameters were much different with ΔH, ΔG, and ΔS for KR of -5.2 kcal/mol, -7.4 
kcal/mol, and -20.1 cal/(mol·K).  Most striking difference is that the entropy, which 
indicates a fundamental change in the R-state when it is in red blood cells.   
One of the most significant differences of oxygen-binding between HBSOLN and 
HBRBC was the MWC parameter L.  L is an endothermic constant which describes the T-
state population divided by the R-state population at zero oxygen concentration.  At 
20°C, ΔGL is more exergonic for HBSOLN than HBRBC, indicating a decrease in oxygen-
binding affinity.  While the ΔSL greatly increased from HBSOLN to HBRBC, the smaller 
endothermic ΔHL for HBSOLN as compared to HBRBC overcame the effects of ΔSL.  We 
propose the difference in L results from a difference in hemoglobin solvation, in which 
water is more oriented on the hemoglobin surface in red blood cells.  Numerous 
experiments show that the T-state is more stable than the R-state at zero oxygen 
concentration.76,77  The ratio of surface area to volume increases from the T-state to the 
R-state.  Furthermore, the surface area of the R-state is more hydrophobic than the T-
state.  The difference between the hydrophobic surface area of the R-state to the T-state is 
roughly 420 Å2 based on Kyte-Doolittle simulations.  This equates to 67 ordered water 
molecules, as confirmed through osmotic pressure experiments.78   The hemoglobin 
hydration shell effect is likely to be the major cause of the loss of approximately 20 
cal/(mol·K) entropic energy when comparing HBRBC to HBSOLN.  It is significant because 
red blood cells are 96% hemoglobin by dry weight and 35% (w/w) of the total content.79  
As a result, each hemoglobin tetramer in the red blood cell is hydrated by about 6800 
water molecules, with a significant portion of them bound in the first and second 
hydration spheres and leaving little for bulk water. In fact, other researchers have already 
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found that the rate-limiting step of hemoglobin cooperativity is the ordered binding of 
water molecules to the extra protein surface exposed on the transition from the low-
affinity T to the high-affinity R-state of hemoglobin.78  Due to the high concentration of 
hemoglobin in the red blood cell (fig. 1.2), there are hemoglobin-hemoglobin interactions 
that would not occur nearly as frequently in HBSOLN, which may block the R-state of 
HBRBC from binding as many waters in the hydrophobic regions as the R-state of HBSOLN.  
This difference suggested that the dehydrated environment of the red blood cell 
facilitated a shift from the T-state to the R-state as compared to HBSOLN.  This suggests 
that water should be considered an allosteric effector of hemoglobin. 
 Another of the most significant differences of oxygen-binding between HBSOLN 
and HBRBC was the MWC parameter KR.  KR is an endothermic constant which describes 
oxygen-binding of the R-state.  At 20°C, ΔGKR is slightly more exergonic for HBSOLN 
than HBRBC, indicating a decrease in oxygen-binding affinity.  While the ΔSKR greatly 
decreased from HBSOLN to HBRBC, the larger exothermic ΔHKR for HBSOLN as compared 
to HBRBC overcame the effects of ΔSKR.  We propose the difference in KR results from a 
difference in hemoglobin solvation, in which water is more oriented on the hemoglobin 
surface in red blood cells.  We propose that HBRBC forms octamers or higher order 
quaternary structures in the red blood cell for the R-state.  Higher order quaternary 
structures have been elucidated for concentrated sickle hemoglobin, and these are 
hypothesized to be sickle cell fibrils displayed in the sickle red blood cells.80  Higher 
order quaternary structures above tetramers have been verified in several experiments 
with hemoglobin A, but these conditions are not under physiological conditions.81–84  The 
increased concentration of the red blood cell may induce further hemoglobin tetramer 
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interaction than hemoglobin in dilute solution.  The R-state would be more affected than 
the T-state due to the increased interaction of the hydrophobic surface areas between two 
tetramers, causing a difference in ΔSKR. 
 Further experiments would elucidate the higher order quaternary states of 
hemoglobin in the red blood cell.  FRET acceptor-donor experiments with increasing 
hemoglobin concentration in microgels could show the octamer formation at a certain 
concentration.85,86  The concentration within the red blood cell can be increased and 
decreased with osmotic pressure.  Aa solute that does not cross the membrane nor acts as 
an allosteric effector could affect the osmotic pressure.  As the osmotic pressure increases 
or decreases, the hemoglobin concentration changes in the red blood cell.  Elucidating the 
oxygen-binding curve in these conditions could add further understanding of oxygen-
binding thermodynamics of hemoglobin in the red blood cell, and continue further 
knowledge of human oxygen-binding delivery for the body. 
5. Appendix 
5.1 MWC Oxygen-Binding Thermodynamic Parameters 
The van’t Hoff plots of the deoxygenation of HBRBC and HBSOLN were linearly 
determined from the three MWC thermodynamic parameters.  The three MWC 
thermodynamic parameters were globally fitted using OriginPro.  The thermodynamic 
parameters of the oxygen-binding curves of HBRBC and HBSOLN are reported in tables 5.1 












Table 5.1: MWC Parameters of Hemoglobin in Solution 
Temperature L KR KT 
13°C 9120 ± 2.0% 0.833 ± 0.5% 0.0071 ± 0.7% 
18°C 9830 ± 1.4% 0.532 ± 0.4% 0.0061 ± 0.3% 
20°C 10330 ± 1.8% 0.466 ± 0.5% 0.0056 ± 0.4% 
25°C 11480 ±1.1% 0.369 ± 0.8% 0.0055 ± 0.2% 
Listed here are the MWC parameters of the oxygen-binding curves of hemoglobin in 
solution 
 
Table 5.2: MWC Parameters of Hemoglobin in the Red Blood Cell 
Temperature L KR KT 
18°C 860 ± 2.0% 0.352 ± 0.5% 0.0071 ± 0.7% 
20°C 1090 ± 1.8% 0.337 ± 0.4% 0.0061 ± 0.3% 
26°C 1680 ± 1.6% 0.274 ± 0.6% 0.0058 ± 0.4% 
32°C 2460 ± 2.3% 0.243 ± 0.5% 0.0056 ± 0.4% 
37°C 3420 ± 2.0% 0.199 ± 0.1% 0.0055 ± 0.2% 
Listed here are the MWC parameters of the oxygen-binding curves of hemoglobin in the 




5.2 Wavelength Dependent Effects  
In earlier studies, it was found that the oxygen-binding curve of hemoglobin in 
solution had wavelength-dependent effects from 515-585 nm.87,88  Any 
spectrophotometric study in this region must consider that the percent oxygen bound to 
hemoglobin does not relate linearly with Beer’s law.  Such data must therefore be 
globally fit to accurately determine binding constants for this process.  The oxygen-
binding curve of hemoglobin from 615-650 nm measured in the ICAM was found to be 
wavelength-independent.  In a single deoxygenation experiment, the oxygen-binding 
curves were determined at each individual wavelength from 615-650 nm, and the 
differences in fractional saturation between the wavelengths was found to be within the 
error of the ICAM spectrophotometer, and no pattern could be established.  In the present 
studies, measurements were obtained at 620 nm, where fractional absorbance changes 
correspond directly to fractional ligand binding and require no additional global fitting. 
5.3 Buffers and the Intracellular Chemical Environment of the Red Blood Cell 
Hemoglobin oxygen-binding is greatly affected by allosteric effectors, as determined 
by Bohr and others.89,90  In addition, the red blood cell membrane was a hurdle for our 
experiments, as concern that any differences between the intracellular environment and 
the external environment would skew the oxygen-binding of hemoglobin as compared to 
hemoglobin in solution.  As such, phosphate-buffered saline (PBS) was used.  At 100 
mM, phosphate maximally mimics the diphosphoglycerate (DPG) effect of blood 
plasma.89  Phosphate can pass through the cell membrane equally as well as DPG.  Any 
DPG that might have remained in the red blood cells after multiple washes would be 
overwhelmed by the phosphate, as the hemoglobin in solution would be allosterically 
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affected in the same manner.  Additionally, the pH of phosphate buffer minimally 
changes from 14°C-37°C.  While the pH meter was calibrated at the desired temperature, 
this made pH adjustments minimal.  Also, the PBS buffer contained 1% (w/v) sodium 
chloride.  This kept the red blood cells isotonic at physiological salt concentrations.  
5.4 HBRBC Oxygen-Binding Thermodynamics Assuming No Cooperativity 
At low hemoglobin concentration and high oxygen content, the hemoglobin 
tetramer can dimerize into αβ subunits.91  The dimer has no cooperativity, and the two 
binding sites of each monomer is equivalent.  The dissociation constant of hemoglobin 
(KD) from tetramer/dimer at room temperature in phosphate-buffered saline is 1 µM-1.  
KD increases up to 25 µM-1 at 37°C.  Keeping the HBSOLN concentration above 150 µM 
effectively eliminated the tetramer/dimer dissociation at room temperature.  At higher 
temperatures, the concentrations necessary to eliminate tetramer/dimer dissociation was 
beyond the detection of the ICAM spectrophotometer.  The oxygen-binding of HBRBC 




1 + 𝐾𝐾 ∗ [𝑂𝑂2]
. 𝟔𝟔.𝟏𝟏 
The equation was written for each individual monomer of hemoglobin, but if the 
binding sites are equivalent, then K can be scaled to dimers by halving it.  The fits of 
HBRBC deoxygenation from chp.4 did not fit well (fig. 5.2).  The average standard 
deviation had 14.4% error (table 5.3).  This result shows that tetramer/dimer dissociation 







Figure 5.1: Oxygen-Binding Curves of HBRBC at Varying Temperatures Assuming No Cooperativity 
 The oxygen-binding curves at 18, 20, 26, 32, and 37 °C of HBRBC are shown here from A-E, respectively.  The data is shown 
as the black dots, the blue line is the fit using eq. 2.3 (single-binding site thermodynamics), and the error residuals are shown as errors 






Table 5.3: Oxygen Binding Thermodynamics of HBRBC Assuming Dimer 
Thermodynamics 
Temperature (°C) KDIMER (µM-1) Σ 
18 0.0330 ± 0.00040 0.144 
20 0.0287 ± 0.00042 0.144 
26 0.0186 ± 0.00026 0.148 
32 0.0180 ± 0.00004 0.139 






5.5 Red Blood Cell Storage, Retrieval, and Survival 
Introduction 
Blood transfusion was the most important medical advance of World War I with 
the development of a citrate-glucose solution used to store blood.92  At the time, however, 
it was not clear how to store frozen blood and later recover it.  In the 1950s, Lovelock 
stated that the damage to red blood cells during the freezing and thawing process was due 
to the osmotic stress.93  It was thought that the storage of red blood cells would eliminate 
the problems associated with erythrocyte suspensions in transfusion: seasonal shortages, 
rare blood types, and natural disasters.  Two main groups of cryoprotectants have been 
developed, classified as “penetrating” and “non-penetrating.”94  The former, such as 
glycerol, invade the cell and change the osmotic equilibrium during freezing.  In this 
way, the volume reduction due to intracellular ice formation is reduced.  The second 
group of cryoprotectants form a shell around the erythrocyte in a process called 
vitrification, and in this way, protect the red blood cells from osmotic damage.  During 
the freeze-thaw-wash (FTW) processing of red blood cells, there are two main problems.  
One of them is the initial lysis of red blood cells, and the second is the post-thawing 
survivability of the red blood cells.  If enough osmotic damage occurs, or if the cell 
function is limited after post-FTW, or if the cell cannot maintain integrity in the thawing 
solution, then hemolysis will happen rapidly over the course of a few days.  Our goal 
post-FTW is focused on the latter.   We make the assumption that post-FTW survivability 




The goal of post-FTW survivability is based upon post 24-hour transfusion 
survival rates.  National Academy of Science NRC has arbitrarily established a survival 
of 70% in 24 hours post-transfusion as the acceptable level for the viability of preserved 
erythrocytes.  For our work, we arbitrarily set our goal as less than 1% per day.  This 
would ensure a sample that would remain relatively stable over the course of 2-3 weeks.95  
We found that using 40% (v/v) glycerol as a cryoprotectant and using AS-3 storage 
buffer (100 mL H2O, 1.10g of dextrose monohydrate, 0.558g of sodium citrate dihydrate, 
0.276 g of monobasic sodium phosphate monohydrate, 0.42 g of citric acid monohydrate, 
and 0.030 g of adenine) offered our samples three-weeks of adequate post freeze-thaw-
wash survival at 4ºC. 
Materials and Methods 
Initially, our work began with Flegel’s work at the NIH, who focused on using 
polyvinyl pyrrolidone (PVP) as a non-invasive cryoprotectant.96–98. Human blood from 
KH was collected into concentrated ethylenediaminetetraacetic acid, and stored at 4ºC.  
The samples were centrifuged at 1000xg for 5 minutes to isolate the red blood cells.  The 
packed RBC samples had the supernatant removed, and the lost volume replaced with 1% 
w/v NaCl, 50 mM sodium phosphate buffer pH 6.8 (PBS buffer).  This process was 
repeated until the supernatant was clear.  The packed red blood cells were cryoprotected 
in one of two ways: fast-freezing through non-invasive cryoprotectants, and slow-
freezing through invasive cryoprotectants. 
With the non-invasive cryoprotectants, one volume of packed erythrocytes was 




albumin with 23% (v/v PVP in deionized H2O). The mixture was allowed to equilibrate 
for 1 hour.  Afterwards, the mixture was pipetted dropwise into a liquid nitrogen-filled 
Dewar flask.  These droplets were collected with a metal spatula, and placed into a 
cryovial tube with the top punctured several times.  Both the cryovial tubes and the metal 
spatula were chilled with liquid nitrogen beforehand to ensure the droplets didn’t thaw 
and stick on contact.  Afterwards, the cryovial tubes were placed into the -80ºC freezer 
until thawed. 
During the thawing process, the desired amounts of droplets (around 80-160 µL 
each) were placed into 1.5 mL of PBS buffer at 37ºC with gentle shaking.  After 
complete suspension, the sample was washed with storage buffer at 3 fold-excess until no 
hemolysis occurred (around 2-3 washes).  This lowered the PVP left in solution to 
approximately 0.0001 M.  Afterwards, the red blood cells were resuspended, aliquoted 
into individual-use Eppendorf tubes and placed into 4ºC storage until use.  The two 
storage buffers used were 1% PBS buffer and AS-3 solution.  
Valeri’s work with the Naval Blood Research Laboratory focused on invasive 
cryoprotectants.96–98  Two volumes of a glycerol freezing solution (50% w/v glycerol, 1% 
w/v 2-hydroxy-propanoic acid, 1% w/v KCl, 50 mM sodium phosphate buffer, pH 6.8) 
were added for every volume of packed red blood cells.  The mixture was allowed to 
equilibrate for 1 hour.  Afterwards, the mixture was aliquoted into cryovials, and the 
temperature was lowered at 1ºC/min by insulating the test tubes in a room-temperature 
Styrofoam box, which was placed into the freezer and the temperature checked every 




Two different thawing procedures were used to remove the intracellular glycerol.   
The frozen glycerolized samples were warmed to 37ºC.  Afterwards, the samples were 
centrifuged at 1000xg and the supernatant removed.  1 volume of 12% PBS buffer was 
added dropwise to 3 volumes of the thawed RBC sample with gentle mixing, and 
equilibrated at room temperature for 3 minutes.  Afterwards, 3 volumes of 0.2% dextrose 
(w/v), 0.9% saline (w/v) was added dropwise with gentle shaking, then left to equilibrate 
for 3 minutes, and this process was repeated 4 times.  At this point, the sample was 
centrifuged for 3 minutes at 1000xg, and then an eighth of the total volume was aspirated, 
replaced with storage buffer, then the packed RBC were resuspended.  This process was 
repeated 8 times, with the following volumes aspirated and replaced: 1/8th, 1/4th, 3/8th, ½, 
and finally 4/5th.  Afterwards, the RBC samples were aliquoted into one-use Eppendorf 
tubes and placed into the 4ºC refrigerator.  The two storage buffers used were 1% PBS 




5.6 Dissolved Oxygen Concentration 
To determine the concentration of air-equilibrated water, the true air pressure and 
temperature were recorded.  The temperature of the lab was recorded with a thermometer.  
The air pressure and humidity were given by KLNK airport.  The lab was determined to 
be 75 feet above KLNK airport. The true air pressure was given determined by:  
 𝐿𝐿𝐿𝐿𝐿𝐿 𝐴𝐴𝐴𝐴𝐴𝐴 𝑃𝑃𝐴𝐴𝑒𝑒𝑃𝑃𝑃𝑃𝑃𝑃𝐴𝐴𝑒𝑒 = �𝐾𝐾𝐿𝐿𝐾𝐾𝐾𝐾 + �75 𝑓𝑓𝑒𝑒𝑒𝑒𝑓𝑓 ∗
26 𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑
1000 𝑓𝑓𝑒𝑒𝑒𝑒𝑓𝑓 𝐿𝐿𝐿𝐿𝑑𝑑𝑎𝑎𝑒𝑒 𝑃𝑃𝑒𝑒𝐿𝐿 𝑑𝑑𝑒𝑒𝑎𝑎𝑒𝑒𝑑𝑑
��. 5.2 










Where: 𝛼𝛼𝑇𝑇 = the volume of oxygen in liters absorbed by one volume of water when the 
pressure of the gas itself amounts to 760 mm.  
 R = 0.082054 liter atm. deg.-1 mol-1 
 Pb = ambient lab air pressure in mmHg 
 PT = ambient pressure of water at a temperature read from the table 





5.7 Determination of the Transfer Function Equation  
A transfer function relates the scattered light from the ICAM to incident light 
intensity. In the absence of an absorbing sample, such as Mb+, Hb, or RBCs, a small 
background signal, B, is detected that derives from the presence of milk. The intensity 
from the ICAM containing the sample of interest, after subtracting B and then dividing by 
the incident intensity is denoted I*. The transmittance from the ICAM is then related to 
the absorbance of the sample. For the deoxygenation of oxyhemoglobin or oxygenated 
RBCs, at a given temperature, the I* quantity is: 
 𝐼𝐼∗ = 1 − 𝑒𝑒−(𝑘𝑘𝛥𝛥𝑏𝑏𝐶𝐶2[𝛥𝛥𝑏𝑏𝐶𝐶2]+𝑘𝑘𝛥𝛥𝑏𝑏[𝛥𝛥𝑏𝑏]). 5.4 
where the k's are absorption coefficients at 620 nm for the indicated species. The apparent 
fractional saturation of hemoglobin with oxygen in the RBCs was not wavelength 
dependent in the region of 620 nm, where I* was measured, in contrast to the 535-580 nm 
region. Temperature was measured throughout with a calibrated thermistor in the RBC 
suspension. Nitrogen gas saturated with water vapor was passed over the stirred sample, 
and the decreasing oxygen concentration data were collected together with the 
corresponding temperatures. A very small amount of a dithionite solution was carefully 
injected at the end of the deoxygenation procedure to ensure complete deoxygenation. 
The values of I* were evaluated. We found that the apparent absorbance from the ICAM 





At 20°C, the fractional saturation for oxygen binding by hemoglobin at one 
atmosphere in the RBC is essentially 1. In terms of the absorption coefficient, kHbO2, 
within the RBC, the intensity is then: 
 𝐼𝐼∗ = 1 − 𝑒𝑒−(𝑘𝑘𝛥𝛥𝑏𝑏𝐶𝐶2[𝛥𝛥𝑏𝑏𝐶𝐶2]). 5.5 
where [HbO2] is within experimental error of HbT. When oxygen is depleted and 
all hemoglobin is deoxygenated within the RBC, then: 
 𝐼𝐼∗ = 1 − 𝑒𝑒−(𝑘𝑘𝛥𝛥𝑏𝑏[𝛥𝛥𝑏𝑏]). 5.6 
allowing the exponential in equation S1 to be written in terms of fractional 
saturation, Y, to give: 
 𝐼𝐼∗ = 1 − 𝑒𝑒−𝑘𝑘𝛥𝛥𝑏𝑏𝐶𝐶(𝑌𝑌)−𝑘𝑘𝛥𝛥𝑏𝑏(1−𝑌𝑌)∗𝛥𝛥𝑏𝑏𝑇𝑇 . 5.7 
Following oxygen removal, Y=0 and the endpoint reading of I* for the 
deoxygenated RBC is established, yielding the value for kHb at a given temperature. Y can 
then be evaluated over the full temperature range for determination of all thermodynamic 
oxygen binding parameters that characterize oxygen binding for hemoglobin in the RBC. 
The ICAM round-bottom flask was held in place via a clamp attached to a camera 
mount.  The camera mount was stable during experimentation.  The camera mount and 
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